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SUMMARY OF THESIS
Pigeon Fanciers Lung (PFL) is one of the commonest causes of Extrinsic Allergic 
Alveolitis (EAA) or Hypersensitivity Pneumonitis (HP). It is induced by repeated 
inhalation of antigens from pigeons in a sensitised individual. Since the majority of 
fanciers do not develop the disease despite being exposed to similar amount of antigen 
exposure, the host’s susceptibility factors including constitutional and environmental 
factors and the combination of these factors are prerequisite to the development of 
disease. Among these predisposing factors, it has been proposed that certain genetic 
susceptibility such as alleles of the major histocompatibility complex may increase an 
individual’s susceptibility to develop the disease. Other environmental factors such as 
cigarette smoking and amount of antigen exposure may also play a role.
PFL is characterised by inflammation of the lung parenchyma but it also involves small 
and large always. Apart from respiratory symptoms, fanciers with PFL also develop 
systemic symptoms such as fever and myalgia that usually occurs 4-8 hours after antigen 
exposure and can last until 24 hours. The sequence of immunopathological events that 
contribute to the development of PFL is unresolved. Evidence supports the role of 
immune complexes with the exuberant antibody response and the delay in the onset of 
symptoms. T cell mediated response also plays a vital role with the appearance of 
granuloma. It is likely that these 2 processes occur simultaneously and complement each 
other as the immune response progresses.
In view of the different clinical presentations and dynamic nature of the disease, the 
disease can be divided into 3 groups consisting of acute progressive, acute intermittent 
non progressive and chronic disease. Fanciers with an antibody response but without 
symptoms should be regarded as having subclinical disease as there is evidence of
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ongoing immune and inflammatory response and they are at risk of progiessing to 
clinical disease.
This thesis examines the immunological response and its correlation with the clinical 
status and other factors that may influence this response amongst pigeon fanciers. The 
clinical material was collected from a gioup of pigeon fanciers from the North West 
Federation Fanciers and also from pigeon fanciers attending pigeon shows mainly in 
Blackpool.
Most of the studies in PFL are done on patients attending clinics or volunteers attending a 
pigeon show and there is a lack of epidemiological data. In a cohort of 41 pigeon fanciers 
studied over 5 years, there was deterioration in lung function measured by spirometry. 
These changes were associated with T lymphocytes abnormalities but there was no 
change in the clinical status over the 5 year period.
Part of this study examined a large population of pigeon fanciers and found that the 
majority of fanciers showed evidence of sensitisation. Specific IgG antibody to avian 
antigen is a good indicator for antigen exposure and is an important part of the diagnostic 
workup. The IgG antibody response against avian antigen was quantified by ELISA in a 
population of pigeon fanciers and measured against several constitutional and 
environmental factors that may affect the antibody response. The ability to produce an 
antibody response seems to increase with age but the response is not influenced by the 
amount of antigen exposure. Therefore the antibody response appeared to be determined 
by the individual’s own immunological responsiveness rather than the amount of antigen 
exposure. Cigarette smoking inhibited IgG antibody production and this effect appears to 
be reversible as the antibody levels in ex smokers is similar to non-smokers. Fanciers 
with the highest amount of antibody production tend to be the most symptomatic. There 
was an association between increase incidences of PFL with progressively higher 
antibody production. The incidence of probable PFL was 42% in fanciers with a IgG 
antibody level of above 30ug/ml. There was also no proven correlation between IgG 
antibody response and airflow limitation among the pigeon fanciers. Some fanciers
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without any evidence of sensitisation had respiratory symptoms similar to PFL that may 
be due ornithosis or to many other antigens and irritant dusts that has been shown to be 
present in the pigeon loft.
Animal studies have supported the role of cytokines in the pathogenesis of HP. The initial 
acute symptoms in PFL suggest the involvement of proinflammatory cytokines and the 
regulatory cytokines are involved in polarising the lymphocytes primarily towards a Thl 
type response. In this thesis the role of proinflammatory and regulatory cytokines were 
studied. In fanciers with symptoms suggestive of PFL there was an increase in 
proinflammatory cytokines TNFa, IL-lp, IL-6, IL-8 and regulatory cytokines IL-18. 
These antigen induced cytokine levels correlated with the avian antigen specific serum 
antibody level. There was no difference in the constitutive or endotoxin inducible level of 
this cytokines suggesting that the cytokine production mediated by immune complexes 
was quantitatively and qualitatively different fi’om cytokine profile produced by 
endotoxins and may predispose to disease. Studies have shown that T cell responses 
produce different patterns of cytokine production. The ability to produce high or low 
amount of cytokines and the interaction between them may determine the susceptibility 
of the individual as these cytokines may provide protection or stimulate pathological 
immune responses in the individual.
T cell lymphocyte abnormalities have been suggested to be involved in the pathogenesis 
of airflow limitation in patients with COPD. This thesis examined the association 
between FEVl and CD8+ T cell lymphocyte and found that fanciers with symptoms 
suggestive of PFL had a significant increase in CD8+ cells and there was an association 
between FEVl and CD8+ lymphocytes in peripheral blood among the pigeon fanciers.
This study emphasises the complexity and the dynamic nature of this disease. The 
variation in each individual’s immune responsiveness towards avian antigen and the 
various different immunological mechanisms involved in the disease process is 
highlighted.
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CHAPTER 1
INTRODUCTION AND REVIEW OF
LITERATURE
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1. INTRODUCTION
There are more than 80,000 registered pigeon fanciers in the UK and can be found in 
almost all countries in the world. Although the hobby is concentrated around previous 
mining and industrial areas it is practiced thioughout the country and not confined to any 
particular socioeconomic group.
Pigeon Fanciers Lung (PFL) is a form of extrinsic allergic alveolitis (EAA)/ 
hypersensitivity pneumonitis (HP) caused by repeated inhalation of pigeon antigens in 
sensitised subjects. HP is caused by a wide variety of antigens (Table 1). The antigens 
include bacteria, organic materials, fungal and chemicals. The exposure to these antigens 
occurs in various settings including occupational, hobbies and the environment. Although 
the antigens are specific for each of the syndromes the clinical presentation of the 
different syndromes is similar suggesting the subsequent hypersensitivity reaction is 
homogenous.
The pathogenesis of PFL is thought to be as a result of type 3 hypersensitivity reaction/ 
immune complex mediated response with the presence of avian antigen specific 
antibodies in the serum and BAL of affected individuals. There is also a delay in the 
development of symptoms and the timing and histological findings are similar with an 
Arthus like skin reaction. However the appearance of granuloma in the lungs and 
asymptomatic individuals with a positive antibody levels suggests involvement of type 4 
hypersensitivity reaction/ cell mediated immune response as well. The two may occur 
either simultaneously or at different stages of diseases where the immune complex- 
mediated immune response induces the acute lung injury via complement-dependent 
neutrophils and the T cell mediated immune responses induces granulamatous reaction in 
the later stages.
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Of the various HP syndromes, Farmer’s Lung and PFL are the commonest form that has 
been studied. There has been a decrease in the incidence of Farmer’s Lung due to the 
changes in the farming practice. PFL is now the most commonly HP that presents to the 
clinic and studied. It has considerable research potential as a model for lung inflammation 
(Table 2). Previous studies are based on patients presenting to the clinic and volunteer 
pigeon fanciers attending pigeon shows. The majority of pigeon fanciers who present 
themselves to clinics or participate in research do have evidence of sensitisation but only 
a minority will develop the disease. There is a lack of epidemiological study of this 
disease and no good data on disease prevalence.
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Syndrome
Microbes / Funeal
Antisen
Farmer’s Lung Thermophilic actinomycetes 
Saccharopolyspora rectivirgula 
(Micropolyspora Faeni) 
Thermoactinomyces vulgaris
Bagassosis Thermo actinomyces sacchari
Mushroom Workers Lung Thermoactinomycete sp 
Agarieus hortensis spores
Humidified Lung Micropolyspora faeni
Suberosis Pénicillium frequentans
Malt Workers Lung Aspergillus clavatus
Woodworkers Lung Pénicillium chrysogenum
Cheese Washers Lung Pénicillium casei
Maple Bark Strippers Lung Cryptostroma corticale
Paprika Splitters Lung Mucor stolanifer
Hot Tub Lung Mycobacterium avium intracellulare
Summer type HP Trichosporon cutaneum
Sax Lung Candida albicans
Animals
Pigeon fanciers lung Avian proteins
Animal handlers lung Laboratory animals
Fish meal workers lung Fish meal extract
Rat handlers lung Rat serum proteins
Chemicals
Isocyanates Paints, plastics
Anhydrides Plastics
Table 1. Causative agents causing EAA/HP
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2. CLINICAL 
i) Symptoms
PFL is a complex dynamic clinical syndrome where clinical expression depends on the 
external antigens interacting with the host’s immune system. This is complicated by self- 
regulatory measures performed by fanciers to reduce antigen exposure. There are many 
individuals with a positive antibody reaction but remain asymptomatic.
HP traditionally has been described as occuning in a state of acute, subacute and chronic 
form. The symptoms of acute phase (Table 3) tend to occur 4-8 hours after exposure of 
offending antigen and persist up to 12 hours. Symptoms usually resolve within 24 hours 
unlike a viral infection.
Given the dynamic nature of the disease and evolution of different clinical patterns over 
time an alternative classification system has been proposed (1,2).
1. Acute progressive -  patients experience severe symptoms after antigen exposure and 
symptoms progiess after each subsequent exposure such that patient often recognises 
the problem and usually try to modify their antigen exposure or stop antigen exposure 
completely. Clinically they may be pyrexial and have bilateral crackles on chest 
auscultation with radiological changes on chest radiograph. They may require 
admission to hospital for treatment because of respiratory compromise or the severity 
of symptoms.
2. Acute intermittent non-progressive -  this is the commonest foim of disease in this 
British pigeon fanciers population. Fanciers develop similar symptoms as acute 
progressive disease but less intense and they feel well in between episodes. Many of 
these subjects recognise and indeed anticipate symptomatic episodes after certain 
activities involving greater than normal exposure to their birds (Table 4). They 
continue to have exposure to the antigen and paradoxically symptoms may be less
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severe with recuiTent exposure. Their long term clinical picture appears stable with no 
deterioration in clinical status or lung function. Bourke et al studied the longitudinal 
course of PFL in a gi'oup of pigeon fanciers 10 years after they presented with the 
acute form of diagnosis and despite continued antigen exposure the symptoms related 
to pigeon antigens had improved in the majority of patients and lung function 
remained stable (3). Studies in animal models have also shown that continued antigen 
challenge results in waning of the pulmonary inflammatory response rather than 
progression of disease (5,6).
3. Chronic progressive disease- this may occur in patients following recurrent acute 
episodes or may occur insidiously without any history of acute episodes (7). In the 
insidious group, most patients have few acute symptoms if any and the symptoms 
may be non specific such as worsening dyspnoea on exertion, anorexia, weight loss, 
malaise and cough. There is often a delay in making the diagnosis and this is the form 
of the disease in which the patient presents with permanent disability such as chronic 
shortness of breath, pulmonary fibrosis and respiratory failure. It is often 
indistinguishable ftom other forms of fibrotic lung disease. The history of avian 
antigen exposure may be the only clue in the diagnosis and on occasions subsequent 
avoidance of antigen may not reverse the disease (8).
4. Subclinical disease -  there is a large overlap in antibody response between 
symptomatic and asymptomatic pigeon fanciers. Fanciers with antibody response but 
without the symptom warnings and subsequent modification of antigen exposure, 
may progress to the chronic, non reversible form. Although these patients may not 
have obvious clinical symptoms there is evidence that there is ongoing 
immunological and inflammatory response from the host.
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1. Population at risk identified
2. Obvious source of antigen
3. Antigen available
4. Exposure indices can be measured
5. Antibody response can be measured
6. Relationship between symptoms and immune response 
can be establish
Table 2. Model for lung inflammation
Systemic Respiratory
Fever Cough
Sweating Breathlessness
Myalgia Wheeze
Aching joints Chest tightness
Headaches
Flu like symptoms
Table 3. Respiratory and systemic symptoms of PFL.
Early in season when young birds are taken in a car to a distant location to train them 
During race times (May to August) when fanciers spend many hours in loft 
When lofts are cleaned out
When the birds moult and shed their feathers (September to November)(4)
Table 4. Seasonal presentation of pigeon fanciers lung
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Surveys of pigeon fanciers have also revealed a variety of other symptoms (Table 5) that 
suggests there are many sources of antigenic sensitisation, infection or inflammation 
associated with pigeons. Although EAA/HP is the commonest, many other diseases have 
similar symptoms and presentations.
There is a high prevalence of chionic bronchitis among non smoking pigeon fanciers and 
these increases with higher antibody levels. 8.4% of pigeon fanciers surveyed had chronic 
bronchitis as their only manifestation of pigeon symptomatology (9,10). The increase in 
incidence of asthma and rhinitis in pigeon fanciers may be due to other antigens such as 
bird feather mites or storage dust mites. Some fanciers complain of immediate symptoms 
after exposure such as cough, wheeze, sneezing and watering of eyes. This may be due to 
larger airborne particles, which trigger IgE mediated hypersensitivity responses that gain 
access to the large airways, nasal mucosa and the conjunctivae. Human ornithosis is due 
to cross infection from pigeons, which harbour many organisms that can infect humans 
(Table 6). Evidence of sensitisation to respiratory viruses has been reported but explained 
as an inflammation associated anamnestic response (11). Despite maintaining healthy 
birds, serological sensitisation to chlamydial psitaci among pigeon breeders is common 
(12,13).
It is not known what factors determines the initial presentation and clinical course of the 
disease. The development of clinical disease depends on the antigen exposure, host’s 
susceptibility and the resulting level of dysregulation of the cellular and immune response 
over time. Table 7 shows the constitutional and environmental factors that may affect the 
susceptibility of an individual to the antigen and the development of the disease.
The level and intensity of antigen exposure may be an important factor in the 
development of disease. In Mexico the disease tends to affect women and tends to favour 
the development of the chionic fomi of disease and development of pulmonary fibrosis 
(22). The practice of keeping small number of pigeons at home as pets, providing 
prolonged low giade antigen exposure may explain this. This is in contrast to British
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EAA/HP “ commonest 
Chi onic bronchitis (9) 
Bronchiolitis (46)
Asthma and rhinitis (107-109) 
Human ornithosis
Table 5. Diseases associated with pigeons
Bacteria Chlamydia sp. Mycoplasma, M avium, E coli
Fungi C. Albicans, aspergillus
Viruses Adenovirus, Influenza
Parasites Trichomonads
Mites Diplaegidia columbae
Table 6. Pigeon associated organisms
Constitutional Environmental
Age
Genetic factors -  HLA phenotype (14) 
Cytokines (18,19)
Smoking (15)
Antigen exposure 
Loft ventilation (16,17) 
Infection-viral, bacterial (20,21)
Table 7. Constitutional and environmental factors affecting the susceptibility to develop 
the disease
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pigeon fanciers, where they tend to be exposed to intermittent high levels of avian 
antigen when in their pigeon lofts where the commonest form of the disease is acute 
intermittent non-progressive. There is a seasonal variation in antibody levels among 
pigeon fanciers depending on the time spent on training their birds during the racing 
season and the increase in the amount of antigen exposure when the pigeon moult and 
shed their feathers (4). Air sampling studies have shown a significant increase in the 
amount of respirable dust level and antigen content during the autumn moult 
corresponding to the increase in expression of clinical symptoms among pigeon fanciers 
during that period (17)
Viral infections are known to modulate the immune response. Some patients report that 
though they had been exposed for years, the symptoms only appeared after an acute 
respiratory infection. Mice infected with Sendai virus and simultaneously sensitised with 
antigens develop an enhanced response to the antigen that persists even after the viral 
infection has resolved. Viral infections can increase the antigen presenting capacity of 
alveolar macrophages by increasing the MHC class 1 and 11 molecule expression (20). It 
contributes to the accumulation and proliferation of lymphocytes by increasing the 
expression of adhesion molecules ICAM-1 and VCAM-1 and major histocompatibility 
antigens (23). Viruses also induce pro-inflammatory cytokines and production of 
interferon gamma and IL-8 favouring the proliferation of TH-1 lymphocytes that are 
putatively associated with HP.
The genetic differences between individuals must be important in determining the clinical 
outcome of exposure. The genetic polymorphism for production of high or low amounts 
of inflammatory cytokines may be involved. Pigeon fanciers with HP has been shown to 
have an increase of the frequency of HLA -DRBU1305, HLA-DRQB 1*0501 and TNF- 
a  (308) promoter which is associated with high production of TNF-a (14). This study 
looked at the role of pro inflammatory and regulatory cytokines in determining the 
susceptibility to the disease.
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ii) Investigations
There is no single test specific for PFL (Table 8). Physical examination is often unhelpful 
in establishing the diagnosis but the presence of crackles on auscultation of the chest an 
fever should alert the clinician of the possibility of the disease. Routine blood tests are 
usually not helpful. There may be an increase in the erythiocyte sedimentation rate, C- 
reactive protein, leucocyte count and gammaglobulins. The rheumatoid factor is often 
positive although the exact cause of this is unknown (24). The avian IgG antibody will be 
increased in the majority of individuals exposed to avian antigen and is a good marker for 
monitoring ongoing inflammatory response. However there are cases of reported negative 
antibody response in patients although this may be because of the insensitivity of the test.
The radiological findings on chest radiogiaph and high resolution computed tomography 
(HRCT) of the chest could provide important clues towards the diagnosis of PFL. The 
radiographic findings will correlate with the stage of the disease. In the acute stage the 
CXR findings include diffuse gi'ound-glass opacification and fine nodular or 
reticulonodular pattern, often involving the lower zones. This reticulonodular pattern 
becomes more prominent with ongoing inflammation. In the chronic disease, the findings 
include upper lobe fibrosis, reticular opacity, volume loss and honeycombing (25).
HRCT is significantly more sensitive than chest radiograph for detecting PFL (26). The 
findings on HRCT have been correlated with histological findings and lung function 
abnonnalities in HP (27,28) In the acute stage, centrilobular nodules, which are poorly 
defined and smaller than 5mm in diameter, are found predominantly in the mid and lower 
zones (29,30). Centrilobular nodules probably represent the peribronchiolar lymphatic 
infiltration that is seen in histopathology (28). Ground glass shadowing, which is thought 
to represent either active interstitial inflammation or fine fibrosis (31), is also seen in the 
acute stage (32) and with the presence of centrilobular nodules these changes are highly 
suggestive of FIP (26). Both these changes tend to resolve with cessation of antigen 
exposure (27). It may also show a mosaic pattern and evidence of air trapping (28,33). In 
the chronic stage, irregular opacities, traction bronchiectasis, loss of lung volume and 
honeycombing usually indicates irreversible fibrosis (26).
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Gallium scan and TcDTPA lung clearance shows changes due to lung inflammation but 
is not routinely performed to aid the diagnosis. Lung function tests are mandatory to 
assess any impairment to the lungs and will be discussed later. Provocative testing by 
inhalation challenge is rarely required to be performed to make the diagnosis.
If the above investigations are still not sufficient to confirm the diagnosis the usual next 
step is to obtain bronchial alveolar lavage (BAL) fluid and diagnostic lung tissue.
BAL is a minimally invasive and safe technique that has become a standard diagnostic 
procedure for the majority of patients with interstitial lung disease. The BAL findings in 
interstitial pulmonary fibrosis show a predominant T helper 2 cytokine profile, whereas 
the BAL findings in sarcoidosis and HP are characterised by a dominant T helper 1 
profile. The BAL findings are dependent on the timing of last antigen exposure, stage of 
the disease and smoking habit. In the acute stage there is an influx of neutrophils (34) and 
after 24 hours there will be a predominance of lymphocytosis with a relative 
predominance of CD8+ T cells, interferon gamma and TNF receptors 1 and 2 (35-37). 
The lymphocytosis in BAL correlates with the severity of alveolitis (38) suggesting the 
selective recruitment and retention of these lymphocytes are vital. There is a correlation 
between tissue lung biopsy levels of CCLl 8, which is putatively involved in naive T cell 
recruitment, and the number of lymphocytes recovered from the BAL fluid (39). As the 
disease progress to the chronic fonn, there will be a decrease in the CD4+/CD8+ ratio 
(40) and when fibrosis is established the numbers of neutrophils increases. Obviously 
these studies are performed at one particular time and provide only a fleeting glimpse of 
dynamic responses in the lungs. The lymphocytosis obtained from the BAL fluid may not 
be specific to the disease as lymphocytosis has also been found in asymptomatic fanciers 
and the ratio of CD4+/CD8+ is similar. However there may be functional differences 
where the lymphocyte cells from the symptomatic group showed greater in vitro 
responses to pigeon antigens and to polyclonal mitogen phytohaemagglutinin (41). The 
other cells that are present in the BAL from PFL patients include yôT cells (42), plasma 
cells and eosinophils (43). Mast cells are also present in BAL fluid specimens and the
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Arterial blood gas 
Blood results
Chest radiograph 
CT scan
Gallium scan 
TcDTPA lung clearance
Lung fiinction
Bronchial lavage (BAL)
Lung biopsy
Type 1 respiratory failure in severe cases
IgG antibody to avian antigens
Neutrophil leucocytosis, hypergammaglobulinaemia,
rheumatoid factor positive
Pulmonary infiltrates
HRCT can identify features such as ground glass 
shadowing and air trapping even when the X-ray is normal. 
Uptake reflects alveolar macrophage activation 
Indicates increased alveolar permeability and sub- 
clinical inflammation (75,76)
Restriction of lung volumes, impaired gas 
diffusion, hypoxaemia and airways obstmction 
Initial neutrophil alveolitis followed by lymphocytic 
alveolitis.
Diffuse interstitial inflammation of mainly lymphocytes 
multinucleated giant cells in membranous and respiratory 
bronchioles, gianuloma, constrictive broncholitis and 
fibrosis.
Table 8. Investigations for diagnosing pigeon fanciers lung
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number of mast cells in lung tissue correlates with disease activity (44). The number of 
neutrophil increases when fibrosis develops at the later stage of the disease (45).
Lung biopsy is obtained either by transbronchial lung biopsy or open lung biopsy. The 
histopathological features are distinctive but not pathognomonic and vary depending on 
the stage of disease at the time of biopsy and the adequacy of the lung biopsy sample. 
The characteristic findings include diffuse interstitial inflammation, multinucleated giant 
cells in membranous and respiratory bronchioles, non caseating gianulomas, constrictive 
broncholitis and fibrosis in the later stages of the disease (46). The diffuse interstitial 
inflammation mainly consists of lymphocytes, macrophages, mast cells and plasma cells. 
If there is exposure to endotoxins, there may be significant neutrophilic inflammation as 
well as emphysema.
iii) Diagnosis
The variability in the clinical presentation of PFL and its similarity with other diseases 
can lead to the underdiagnosis of PFL. The most important pointer towards a diagnosis is 
exposure to the relevant avian antigen which should be obtained fi’om the initial history 
taking. The relationship between avian exposure and initial onset of symptoms as well as 
recurrent episodes related to exposure is often evident. Respiratory and systemic 
symptoms related to avian antigen exposure with a positive antibody response is usually 
enough to make a diagnosis without obtaining BAL fluid and lung biopsy. While the 
BAL fluid is characterised by an accumulation of CD8+ cells, this is not unique to this 
disorder as this can also be found in BAL of patients with AIDS, collagen-related 
disorders, silicosis and dmg induced pneumonitis. Therefore the diagnosis of PFL can 
remain difficult and may rely on histopathology. Table 9 lists the common diseases that 
need to be considered in the differential diagnosis.
In a recent review of diagnostic criteria by a committee they identified six significant 
predictors of EAA/HP: exposure to the known offending antigen, positive precipitating
Other causes of hypersensitivity pneumonitis
Other causes of diffuse lung diseases such as idiopathic pulmonary fibrosis 
Acute bronchiolitis or pneumonia 
Acute endotoxin exposure 
Asthma
Acute dust toxic syndrome
Allergic bronchopulmonary disease
Pulmonary embolism
Aspiration pneumonitis
Bronchiolitis obliterans organizing pneumonia
Mycobacterial, fungal, viral infections
Chronic beryllium disease
Sarcoidosis
Churg Strauss syndrome 
Wegener’s gianulomatosis 
Lymphoma/leukaemia 
Bronchiectasis
Table 9. Differential diagnosis of PFL
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antibodies to the offending antigen, recurrent episodes of symptoms, inspiratory crackles 
on physical examination, symptoms occurring 4-8 hours after exposure and weight loss. 
Exposure to the offending antigen was the strongest predictor for EAA and the 
probability of having EAA ranged from 0% with none of these features to 98% with all 
six (47,48).
iv) Management and Treatment
Pigeon fanciers have a strong affinity for their birds and sport. Our data has shown that 
on average they spend on average 18 hours per week in their lofts looking after 85 
pigeons on average. The time spent in the pigeon loft is considerably more during the 
racing season. They have made a considerable financial and emotional commitment and 
its social interactions often dominate their lives. It is unlikely that a pigeon fancier would 
consider giving up their lifestyle and commitment to their sport without looking at other 
options. They may be reluctant to seek medical attention in fear of being told to give up 
their birds. Medical staff should understand that giving up the pigeons is not an initial 
option but only as a last resort if other methods have been found to be ineffective in 
controlling their symptoms.
The most important intervention in managing this condition is to reduce the amount of 
avian antigen exposed and inhaled. This can be done in several ways.
1. Reducing the time spent with their pigeons.
This may be difficult to adhere because fanciers develop their skills and 
experience as a result of spending time in contact with their pigeons, training and 
breeding them to develop their homing instinct. The time in contact with the 
pigeons should be reduced and excessive handling of them discouraged. 
Someone else can perform the daily cleaning of the loft or taking the pigeons 
away for training flights.
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2. Wearing a suitable mask.
This will filter out 90-95% of respirable particles therefore reducing the amount 
of antigen inhaled. In the majority this intervention will dampen the immune 
response.
3. Wearing a dedicated hat and coat while in the loft.
Antigenic dusts have also been measured in the home environment (17). This 
may be carried into the home from the loft on clothing and hair of the fanciers. 
By wearing a dedicated hat and coat in the loft area this will help to reduce the 
spread of bloom ft'om the loft area. Fanciers should also wash their hands after 
handling their birds. These antigenic dusts can persists for up to 18 months in the 
home environment after removal of birds and may be the explanation where there 
is a persisted positive avian antibody level despite giving up their pigeons (49- 
51).
4. Loft management strategies
Pigeon lofts are generally dusty and fanciers are exposed to significant amount of 
antigenic dusts which are mainly derived from pigeons and consist of pigeon 
droppings, feather dust (bloom) and dust from grain feed.
Lofts using the deep litter method where droppings accumulate, dry out and 
become fine chalk like powder which absorbs fresh dropping have significantly 
higher levels of antigenic dust compared to lofts that are cleaned daily which is 
the more common method (16). Lofts should also be designed for minimising the 
amount of antigenic dusts being inhaled by fanciers and various loft ventilation 
strategies can be adopted for this purpose.
There are no randomised double blind placebo controlled trials of corticosteroid therapy 
in Pigeon Fanciers Lung but a randomised controlled trial in acute fanners lung found 
that prednisolone improved lung function compared to the control group but there were 
no difference in the long-teim outcome between the two groups (52).
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Patients with symptoms should be considered for a trial of steroid therapy to suppress the 
active immune response. Controlled trials are lacking but there are many anecdotal 
reports of the beneficial effects of systemic steroids in the acute stage of the disease. 
Severe attacks may necessitate treatment with oral prednisolone 40-60mg daily with 
supplement oxygen therapy and other appropriate supportive measures. The effects of 
steroids on the long term course of PFL are unknown. In one study of PFL, there were no 
significant clinical outcome differences between cases who were treated with steroids and 
those who were not (53). Patients with complaints of cough, wheeze and chest tightness 
with airflow obstruction may benefit fr om inhaled steroids and beta agonists therapy (54). 
There is no data from controlled trials regarding the efficacy of the inhaled steroids in 
PFL. The effectiveness of the steroid trial and antigen avoidance measures can be guided 
by clinical symptoms, chest radiograph, lung function and circulating antibody levels.
There is evidence that the long tenn prognosis of farmer’s lung is poor (55) where some 
patient’s progression continued despite avoidance of antigen exposure. For example, 24 
of 61 farmers with acute HP who stopped farming for 3-5 years noted continued decline 
in diffusion capacity and total lung capacity (56). There seems to be several predictors of 
long term decline in farmers such as recurrent episodes, swine confinement areas, 
exposure to bacterial endotoxin, allergy to mites and fungal infections (57). Progiessive 
deterioration of lung frmction indicates progressive disease and the changes are likely to 
be irreversible leading to respiratory failure, cor pulmonale and ultimately death (56-58). 
Lung transplantation may be the last resort in patients with progressive disease and 
unresponsive to medical therapy.
There had been reports that therapeutic doses of erythromycin, which has anti­
inflammatory properties significantly suppresses the neutrophil influx into the lung, 
intradermal Arthus reaction, and the expression of intercellular adhesion molecule -1 in 
experimental HP lesions (59). Therefore erythromycin may be effective in the acute form 
of HP but this requires further studies.
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In children the most common reported cases of HP are due to avian exposure, mainly to 
domestic birds. The outcome of these children who receive proper diagnosis and 
treatment is excellent. In the 67 pediatric cases of HP with outcomes, 65 children 
improved or became asymptomatic, 1 patient was worse, and 1 patient died 9(60).
3. LUNG FUNCTION
During the acute symptomatic phase there is a restrictive ventilatory defect with 
reduction in gas exchange and this return to normal between episodes. There may be an 
increase in alveolar-arterial oxygen gradient on arterial blood analysis and oxygen 
desaturation with exercise suggests early gas exchange abnormalities. This suggests the 
inflammatory disease is mostly at alveoli level (61-64). However, pathological studies 
and animal models of EAA suggest that inflammation is not confined to the alveoli but 
also involves the bronchi and smaller aii*ways (9,65). Subjects with PFL in addition to 
having the well recognised restrictive defect also had a high prevalence of chronic 
bronchitis, large airways involvement and peripheral airway obstruction. Whether this is 
due as part of the immunological response in PFL or as a result of inhaling endotoxins 
present in the pigeon loft is uncertain. The lung function usually improves in fanciers 
who cease exposure but the abnoimalities in lung volumes and diffusing capacity may 
persist in some (66)
In chronic disease there is often evidence or persisting restrictive defect, with reduction in 
gas transfer. When the abnormalities persist or deteriorate despite avoiding antigen 
exposure, this indicates permanent damage to lung stmcture and function. If antigen 
exposure continues this may progi ess to pulmonary fibrosis, with worsening restrictive 
defect and gas transfer and ultimately respiratory failure.
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4. ANTIGEN
There is a range of antigens that can cause alveolitis but the clinical presentation and 
subsequent immunological response is similar to all the different antigens. Antigens 
involved in PFL need to be ideal in size and shape which, when inhaled will penetrate the 
distal alveoli to initiate an immune and inflammatory response. This is in contrast with 
asthma where the antigens involved are larger and are deposited proximally in the 
bronchi causing an IgE reaction in atopic individual. There are many sources of antigen 
whieh have been described from pigeon droppings (67), which have been described as the 
“complete” source of antigens associated with the disease, bloom from pigeon feathers, 
serum, egg yolk and white, crop fluid and gut wall all of which contain mixtures of 
protein antigens (68-70).
Pigeon lofts are generally dusty especially during autumn when the pigeon moult and 
shed their feathers. There is a range of pigeon associated antigens present in the pigeon 
loft. The main source of antigen is bloom. Bloom is a fine dust produced from feathers by 
birds that can fly. It appears like talc powder eoating the surface of pigeon lofts and 
covers the hands, hair and clothing of the pigeon fancier. It is an inert keratin protein 
granule coated with pigeon IgA about 0.75 microns in diameter with the coiTcct 
aerodynamic size to enter the peripheral airways and alveoli and initiate the immune 
response. It is at this alveoli level that the disease process is most apparent. Keratin is 
resistant to enzyme breakdown and may act as an inflammatory foreign body. Fit pigeons 
trained to race produce bloom in copious amount to keep them dry in wet racing 
conditions. In contrast birds that do not fly such as duck, chicken and turkey produce 
minimal amount of bloom explaining the fact that HP among poultry workers is 
uncommon. Fanciers are exposed to bloom when in the loft when handling them or when 
the pigeons fly close to them especially during the racing season when they spend more 
time in the lofts and autumn when pigeons shed their feathers
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Droppings and waste materials in the loft are also antigenic source but less potent 
because they are larger, moist and less readily inhaled. IgA is the major protein antigen in 
droppings (71) but also contains other less defined antigenic materials. Droppings are 
also a source of bacterial endotoxin and fungal glucan, which are proinflammatory (21). 
Disease specific 21-kd proteins from pigeon dropping have been described causing 
lymphocyte transformation only in subjects with PFL (72). Pigeon intestinal mucin is a 
major carbohydrate antigen with a high molecular weight glycosylated protein core that is 
resistant to degiadation and likely to be stable in the pigeon loft environment and difficult 
to clear within the lungs (73,74). Mucin is also found to be abundant in pigeon droppings 
and bloom.
Pigeon serum is the main source of antigen for use in serological and inhalational 
challenge studies where the main antigens are gamma globulin proteins. It contains a 
range of antigens including proteins, glycoproteins and polysaccharides that is detected 
by the sera of sensitised pigeon fanciers (77,78). It is readily available and contains the 
major antigens while avoiding problems with contamination of droppings or bloom 
extracts by microorganisms or other agents (79). There are also other various antigens 
such as bacterial, fungal, viiiises, parasites and mites that have been identified in the 
pigeon lofts that may cause symptoms mimicking PFL (Table 6).
5. IMMUNOPATHOGENESIS OF PFL
The pathogenesis of PFL involves repeated antigen exposure, immunologieal 
sensitisation of the host to the antigen and immune mediated response fi'om the host 
causing pulmonary and systemic symptoms. The immune response is characterised by 
interstitial and alveolar inflammation with granuloma formation (80). This appears to 
involve a combination of immune complex mediated or type 3 reaction and cell mediated 
or delayed type IV immune response to the inhaled antigens. The delay in the onset of 
symptoms after antigen exposure and the high levels of specific avian antigen 
immunoglobulins and complement components in the serum and BAL supports the role
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of type 3 reaction or immune complex mediated response. These immune complexes can 
activate alveolar macrophages and have also been shown to release proinflammatory 
cytokines, particularly TNFa and IL-1 which causes lung inflammation (81-83). Immune 
complex induced lung injury ean be blocked by an antibody to recombinant TNF and 
related proinflammatory cytokines in experimental animals confirming that these 
cytokines are released by immune complexes (18).
There is strong evidence that type 4 allergic reaction or cell mediated immunity are also 
involved in the pathogenesis of PFL. Animal models support the importance of cell 
mediated immunity in HP. Cultured lymphocytes passively transferred from sensitised 
animals to unexposed non sensitised animals results in disease similar to humans when 
the naive animals are subsequently challenged with inhaled or infused intrapulmonary 
antigens (84). Interferon gamma is the prototype of Thl cytokines activating alveolar 
macrophages and is a key factor in the events that favour the local immune responses in 
the lung. Studies using ‘knockout’mice incapable of expressing the gene coding for 
interferon gamma, these mice do not develop significant amounts of granuloma formation 
in the lungs after exposure to antigen (85). Pathologically, gianulomatous interstitial 
pneumonitis with variable degrees of distal bronchiolitis obliterans is the characteristic 
findings in HP and this inflammation is caused by T cell mediated immune response to 
antigens entering the lungs. Therefore, the evidence of the importance of T cell mediated 
immune response includes (a) antigen reactive T cells with an activated phenotype that 
are present in the blood and lung. Peripheral lymphocytes from symptomatic fanciers 
exhibited spontaneous proliferation when challenged in vitro with pigeon serum antigen 
but lymphocytes from asymptomatic fanciers showed no significant proliferation to 
antigen (b) biopsy features typical of T cell mediated immune response and (c) in animal 
models, where the possibility of transferring the disease to healthy animals by adoptive 
transfer of T cells.
The nature of the inflammatory infiltrate reflects the stage of disease. Samplings of 
airway cells and fluid by bronchoalveolar lavage (BAL) have improved our 
understanding of the immunopathology of PFL. However these studies need to be
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interpreted carefully as the studies varies in defining a characteristic positive test, the 
time of exposure and sampling are different and PFL are grouped together with other HP. 
BAL shortly after antigen exposure demonstrates an acute neutrophil infiltrate (34) which 
corresponds with the clinical phase of acute symptoms. This infiltrate becomes 
predominantly lymphocytic after 24-48 hours (86,87) and the proportion of lymphocytes 
recovered by BAL correlates with the degree of lung inflammation (88-91). The 2 
mechanisms that account for the lymphocytosis within the alveolar space are the cellular 
redistribution fiom peripheral blood to the lungs and in situ proliferation. In acute disease 
these lymphocytes are predominantly CD4 T-cells but in more chronic disease CD8 T- 
cells predominate, along with variable numbers of plasma cells, which is not normally 
found in BAL. Both cellular redistribution ft'om peripheral blood to lung and in situ 
lymphocyte proliferation contribute to the increase in CD4+ and CD 8+ T cells in the lung 
reflecting the intensity of the alveolitis and the local immunoglobulin levels (91,92). The 
CD4+/CD8-t- ratio is generally lower than that in the healthy person although this is 
variable depending on several factors such as dose of inhaled antigen, disease stage and 
other non-specific initants present in the environment. There is general mobilisation of 
the immune apparatus of the lung. Bronchus-associated lymphoid tissue (BALT) and B 
cell expansion is induced and is probably maintained by persistent inflammation. The 
expression of nuclear proliferation antigen Ki-67 on the centroblasts located in the BALT 
germinal centres indicates intense local antibody production (93).
B lymphocyte involvement is suggested by the increase amount of antibody response to 
inhaled antigens resulting high titres of IgG antibody in peripheral blood, BAL fluid, 
sputum and saliva in the majority of fanciers. Positive IgA and IgM antibodies to avian 
antigen are also found to be higher in the symptomatic pigeon fanciers (94). The higher 
antibody response correlates with the severity of the disease. However many antibody 
positive fanciers remain asymptomatic suggesting antibody appears necessary, but not 
sufficient to produce disease.
After the antigen is inhaled, it binds to IgG antibody and the immune complex initiate the 
complement cascade and the resulting C5 activates alveolar macrophages which secretes
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chemokines such as M IP-la and cytokines. M IP-la promotes the differentiation of 
CD4+ ThO cells to Thl cells and acts as a chemotactic factor for macrophages and 
lymphocytes. Alveolar macrophages that is important in the pathogenesis of PFL, process 
and presents antigen to the CD4+ cells in the early phase. A vaiiety of cytokines are 
produced ineluding pro inflammatory and regulatory cytokines. Pro inflammatory 
cytokines such as TNF alpha, IL-1 and IL-8 are produced explaining the acute symptom 
of fever and neutrophilia (95). In comparison with other idiopathic pulmonary fibrosis, 
macrophages from patients with HP secrete more TNFa and less IL-1. Regulatory 
cytokines IL-12 and IL-18 are also produced which can polarize lymphocytes towards a 
THl type bias response. Regulatory cytokines such as IL-10 are known to counteract 
many of the biological effects of interferon gamma suggesting that IL-10 plays a role in 
damping down the inflammatory process (96) and granuloma formation. Knockout mice 
and adenovirus-mediated gene transfer of IL-10 to the liver of these mice showed that IL- 
10 has important anti inflammatory properties and the lack of this cytokine leads to 
increase granulomatous inflammation response (97). The distribution of these pro 
inflammatory and regulatory cytokines and the genetic polymorphism (14) that 
determines the amount produced at each stage of stimulation may determine the clinical 
outcome. The crucial distinction between CD4+ and CD8+ T cells pertains to recognition 
of antigens presented by different major histocompatibility complex molecules. Activated 
macrophages also have increase expression of adhesion molecules (CD80, CD86) to 
allow inflammatory cells into the lung tissue and ICAM-1 that is necessary for 
lymphocyte recruitment in the lungs (98,99). The soluble ICAM-1 levels are also 
increased in the BAL fluid (100) and this correlated with physiological indices of lung 
inflammation all of which normalise after cessation of antigen exposure (101),
More advanced disease is characterised by increasing fibrosis with thickening of the 
alveolar septa and basement membrane (102). Activated alveolar macrophages express 
increased amount of TGF-P, a potent stimulator of fibrosis and angiogenesis (103). 
Expression of the Fas ligand and the CD40 ligand systems are also involved in the 
development of fibrosis (104). This fibrosis appears to be related to the proportion of 
aetivated neutrophils (45) and increased numbers of mast cells (105,106).
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6. AIMS OF THESIS
Most of the studies performed are done on patients presenting to clinics or on volunteers 
attending a conference. A part of this research is to look at a cohort of pigeon fanciers in 
a particular area and determine weather there are any changes in lung function, symptoms 
and immunological status in a 5 year period. The relationship between lung function and 
inunune responses among these pigeon fanciers were also explored.
The trend of immune sensitisation among a large group of pigeon fanciers were also 
studied to determine whether there has been any substantial change in the immune status 
over a 13 year period and how these changes occurred.
The presence of semm antibody to avian antigen does not necessary imply presence of 
disease in the individual as many antibody positive fanciers remain asymptomatic. This 
study looked at the evidence of sub clinical disease where underlying inflammatory 
response is ongoing despite no clinical symptoms experienced. The type of immune 
response, clinical presentation and subsequent progression of disease are likely to be 
influenced by various environmental and constitutional factors. These factors determine 
the susceptibility of these fanciers in developing PFL. This thesis attempts to identify the 
role of these environmental and constitutional factors in determining the clinical course 
of disease and the ability to mount an immune response. The association of serum IgG 
antibody with clinical symptoms, incidence of disease and lung frmction were also 
identified.
*
Role of environmental factors studied
Antigen exposure which can be measured -  number of birds kept, average 
weekly exposure and number of years involved 
Cigarette Smoking
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Role of constitutional factors studied
• Age
• Avian antibody production
• Proinflammatory and regulatory cytokines and role of CD8+ T 
lymphocyte
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CHAPTER 2
5 -YEAR LONGITUDINAL STUDY IN 
A COHORT OF PIGEON
FANCIERS
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1. SUMMARY
The immuno-pathogenesis of PFL is unresolved. Most studies rely on subjects presenting 
at clinics and proper epidemiological evaluation is lacking. Bourke et al study evaluated . 
24 patients diagnosed with the acute form of pigeon fanciers lungs 10 years after the 
original diagnosis and found that the majority had stable lung function and improved 
symptoms despite continued avian antigen exposure (2). However, there are no 
epidemiological data on changes in lung function and immunology in a population of 
active pigeon fanciers over a period of time. In this study, a cohort of 41 pigeon fanciers 
had serial lung function, serum antibody IgG and associated symptoms related to inhaled 
avian antigens measured over 5 years.
This study found that between 1997 and 2002 there was a significant reduction in FEVl 
(T = -3.8, p = 0.004) and FEV1/FVC% (T = -3.22, p = 0.003). 22 subjects were 
seropositive in 1997 and a further 3 subjects showed evidence of new sensitisation in 
2002 and there was no significant increase in paired mean IgG antibody titre. There was 
no significant change in the symptoms reported. The FEVl % con-elated inversely with 
peripheral blood CD8 lymphocyte proportion (r = -0.412, p < 0.01) and the IgG antibody 
titre also correlated inversely with the CD4/8 ratio (r = -0.4, p = 0.02). 11 subjects had 
symptoms suggestive of PFL in 2002 eompared to 13 subjects in 1997.
Serial lung function in statistically determined cohort of these 41 pigeon fanciers seems 
to deteriorate significantly despite no change in symptoms reported. These changes are 
associated with underlying immune dysfunction involving the imbalance of T-helper and 
T-cytotoxic lymphocytes. This study also demonstrated that sub-elinical inflammatory 
changes are common among pigeon fanciers and may be predictive of disease 
progression.
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2. Introduction
There is little data on the epidemiology and disease prevalence of pigeon fanciers lungs. 
There are studies on fanciers with positive antibody response to avian antigens and 
disease where the prevalence varies between 11-21% (110-113). These figures are wide 
ranging as the population selection, method of measuring antibody levels and criteria for 
alveolitis differs from each study. The clinical presentation of PFL also varies and may 
be confused with other diagnosis. These studies also may have inadvertently excluded 
symptomatic subjects who are unwilling to be involved in fear of being told to give up 
their pigeons. Despite this, even a conservative estimate of prevalence would generate a 
large number of cases since the number of registered pigeon fanciers in the UK alone is 
80,000 (114). In comparison with Farmer’s lung the incidence reported in the fanning 
communities ranges from less than 1% to 6% in farmers (115,116).
However most fanciers remain asymptomatic despite being antibody positive for avian 
antigen. Most studies are performed on volunteers or patients attending clinics. Many 
symptomatic fanciers are afraid to be told to give up their pigeons and avoid doctors, 
therefore a study on the longitudinal course of this disease is difficult to complete (117). 
The purpose of this study is to assess the longitudinal course of a cohort of active pigeon 
fanciers over a 5 year period.
The elassical abnormalities of pulmonary function tests that have been described are 
associated with a restrictive defect with loss of lung volume, hypoxaemia and 
abnormality of gas exchange with a low diffusion capacity and reduce KCO suggesting 
mostly alveolar involvement (118). However, other studies and animal models of EAA 
suggest that inflammation is not confined to the alveoli but also involves bronchi and 
smaller airways (119). It has been shown that both in pigeon fanciers and farmers there is 
a high prevalence of chronic bronchitis (9,10). This increases as antibody levels rise after 
the typical risk factors such as smoking and dusty atmosphere have been excluded.
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This study looked at the large and peripheral airways involvement over a 5-year period 
measured by spirometry. The immune responses were measured which included IgG 
avian antibody level and T lymphocytes subsets in peripheral blood in 1997 and its 
correlation with lung function. The symptoms experienced by the fanciers related to their 
hobby were also recorded
3. Methods
110 Pigeon fanciers from the North West Federation Fanciers were randomly selected 
from the club’s register of 330. 81 fanciers agreed to participate in the study in 1997. 
Letters were sent out to the 81 faneiers inviting them to participate in the repeat study in 
2002. 41 out of the 81 fanciers agreed to be involved in the repeat the study in 2002.
Data was collected at pigeon marking sessions where fanciers brought their pigeons to be 
marked before racing day. Each subject filled in a self-completed questionnaire, 
performed a spirometry test and provided a 5ml blood sample.
The self-completed questionnaire (Appendix A) was done under medical supervision to 
ensure accuracy of data. The questionnaire included clinical information relating to 
amount of exposure to pigeons, self regulatory measures, symptoms related to pigeon 
exposure, smoking history and other respiratory symptoms in accordance with the MRC 
questionnaire on chronic bronchitis. Spirometry was perfomied with a Vitalogiaph Alpha 
machine and based on the ATS guidelines on perfoiming spirometry testing (Table 10) 
( 120).
IgG antibody to avian antigen were measured by enzyme-linked immunosorbent assay 
(ELISA). The standard protocol is shown in Appendix B.
Subjects are regarded as having pigeon fanciers lung if they have at least one classical 
respiratory (dyspnoea, cough, wheeze or chest tightness) and one systemic symptom 
(fever, sweating or flu like symptoms) oecuning on a regular basis following contact with 
their pigeons with serological evidence of avian sensitisation. Statistical analyses were
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performed using Minitab software. The paired T test was used to evaluate the differences 
in lung function in 1997 and 2002. Pearson correlation coefficient was used to determine 
the correlation between lung function measured and immune responses.
4. Results
Of the original 81 fanciers who took part in 1997, 28 (34%) were smokers. Table 11 
shows the baseline characteristics of pigeon fanciers in 1997 and 2002. Table 12 and 13 
shows the distribution of smokers and non-smokers in 1997 and 2002. In both groups, 
smokers had a signifieantly lower IgG antibody level and a lower mean age. There were 
also more subjects with no evidence of sensitisation to avian antigen in the smoking 
gi’oup.
Out of the 41 fanciers in 2002, 22 fanciers were positive for antibody response to avian 
antigen in 1997 and a further 3 subjects showed evidence of new sensitisation in 2002. 
Among the smokers (10 fanciers) in 2002 only 2 was positive for IgG antibody response 
(in both years) but both had high levels of 58ug/ml and 79ug/ml with significant 
symptoms of PFL. Interestingly one subject who smoked and had no antibody response in 
1997, stopped smoking and his IgG level was 15ug/ml in 2002 with minor respiratory 
symptoms.
5 fanciers stopped keeping pigeons by 2002. Two of the fanciers had no IgG antibody 
response during both years. The other three had significantly elevated levels of IgG and 
symptoms in 1997 and the levels dropped and they became asymptomatic in 2002 
(subject 1,14 and 25)
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Subject IgG 1997 
active
IgG 2002 
Non active
1 100 50.7
14 70 7
25 55 18.2
The mean FEVl, FEV1/FVC% and FEF25-75 for the 41 fanciers involved in both 1997 
and 2002 study are illustrated in table 14.
Between 1997 and 2002 there was a significant reduction in FEVl (T = -3.8, p = <0.05), 
FEV1/FVC% (T = -3.22, p = 0.003) and FEF25-75 (T= 3.03, p= 0.003) in the study 
gi'oup. However there was no significant increase in paired mean IgG antibody titre. 
Although there was a significant decrease in FEVl, FEVl/FVC ratio and FEF25-75 
during the 5 year period, this did not translate into any noticeable deterioration in 
symptoms experienced among the fanciers. The lung function measured by spirometry 
also did not correlate with semm IgG antibody.
FEV1% measured 1997 r=-0.29 p = 0.08, 2002 r = -0.21 p = 0.18
FEVl/FVC ratio 1997 r -  -0.04 p = 0.82, 2002 r= -0.21 p = 0.21
FEF25-75 1997 1--0.028 p = 0.86, 2002 1- -0.29 p = 0.06
In 1997 FEV1% correlated inversely with peripheral blood CD8 lymphocyte proportion 
(Figure 1, i -  -0.412, p=O.OIO). The IgG antibody titre correlated with CD 8 lymphocyte 
count (Figure 2, i-Q.34, p=0.01) and was inversely correlated with CD4/CD8 lymphocyte 
ratio (Figure 3 ,1--0.40, p=0.02).
13 subjects in 1997 had symptoms of acute intermittent non progressive PFL. 2 of the 
subjects stopped keeping pigeons (subject 1 and 14) and no new subjects described 
symptoms of PFL. There was no significant difference in antigen exposure measured by 
number of birds kept and number of weekly hours spent in pigeon lofts within the 2 
groups (Table 15).
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1. Spirometiy calibrated on site
2. Test explained to subject
3. Prepare subject -  ask about recent illness, medication etc
4. Instruct and demonstrate test to subject -  correct posture and manoeuvre 
technique
5. Subject performs a minimum of three acceptable F VC manoeuvre meeting the 
acceptability and reproducibility criteria.
6. The highest reading at any manoeuvre are stored for analysis
Table 10. ATS guidelines on performing spirometry testing (120)
1997 2002
Age 53.5 58.5
No of birds 57 65
Weekly hours in loft 21 23
FEVl 3.28 2.91*
FEVC1/FVC% 76.3 72.9*
FEE 25-75 2.94 2.54*
IgG (ug/ml) 27.2 31.2
Number of fanciers 
sensitized
22 25
Symptom score 2.3 2.1
Table 11. Characteristic of pigeon fanciers in 1997 and 2002 (values are means) *p<0.05
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n Mean age IgG (ug/ml) Seronegative
Smokers 28 48 7.4 16 (57%)
Non smokers 53 54 39.2 14 (26%)
Table 12. Distribution of smokers and non smokers with mean age and IgG levels in 1997
n Mean age IgG (ug/ml) Seronegative
Smokers 10 56 14.1 8 (80%)
Non smokers 31 60 34 8 (25%)
Table 13. Distribution of smokers and non smokers with mean age and IgG levels 
in 2002
FEVl (litre) FEV1/FVC% FEF25-75 (litre) Mean IgG (ug/ml)
1997 3.28 76.3 2.94 27.2
2002 2.91 72.9 2.54 31.2
Table 14. Lung function and IgG antibody results in 41 pigeon fanciers (values are 
mean)
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Figure 2 IgG antibody correlates with CD 8 lymphocyte count
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Figure 3. Correlation between CD4/CD8 and IgG antibody
Average no of birds Average weekly hours in loft % Wearing mask
1997 57 21 38
2002 65 23 36
Table 15 Antigen exposure and % of fanciers wearing mask
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5. Discussion
Serial lung function measured by spirometry in a cohort of pigeon fanciers seems to 
deteriorate significantly over a period of 5 years. However despite these statistically 
significant changes, the fanciers do not complain of any noticeable deterioration in their 
symptoms. This may be due to the initial normal lung function among pigeon fanciers 
and they are able to tolerate the accelerated decline in FEVl and reduction in FEVl/FVC 
ratio and FEF25-75 without developing any appreciable respiratory disability. This is 
further complicated by self-regulatory measures when they develop symptoms where 
fanciers may try to reduce antigen exposure by wearing mask and other attire (coat, hat 
and gloves) as a compromise between their health and hobby. Out of the 41 fanciers in 
2002, 15 wore mask in the loft and all of them apart from one fancier found their mask 
useful in controlling their symptom. Despite having intermittent non-progiessive 
symptoms the majority of fanciers continue with their commitment to their pigeons. 
Certainly there are many reports of fanciers with symptoms who continue to be exposed 
to avian antigen exposure and their symptoms regresses rather than progi*ess despite high 
antibody levels. Animal studies have also shown a decrease in pulmonary inflammatory 
response where repeated antigen challenge is given and the antigen is metabolised 
differently in sensitised animals (121).
Smokers have a significantly lower IgG antibody levels and more subjects without 
antibody response. Smoking appears to suppress the pulmonary immune response and the 
reported incidence of PFL among smokers was found to be lower in previous studies. The 
association between smoking and antibody response will be explored fiirther in chapter 4.
These lung function changes are associated with underlying immune dysfunction 
involving the imbalance of T-helper and T-cytotoxic lymphocytes. The FEVl measured 
in 1997 correlated inversely with CD8+ lymphocytes. Although there was no eoiTelation 
between the deterioration in lung function and IgG antibody responses, the changes in 
antibody response were associated with CD 8+ lymphocyte count and the imbalance of T 
lymphocytes subsets. Recently there has been interest in T lymphocytes subset
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abnormalities in peripheral blood, which might be involved in the pathogenesis of airflow 
limitation (122). Studies have shown a relative decrease in CD4+ T lymphocytes and 
increase of CD8+ T lymphocytes in smokers and non smoking subjects with COPD.
The T lymphocytic infiltrate in lung biopsies of patients with PFL also shows a reduce 
ratio of CD4:CD8 suggesting the imbalance of the T lymphocyte population may have a 
role in the pathogenesis of PFL (123-125). The role of the CD8+ T lymphocytes may be 
important as it can produce cytokines such as gamma interferon, which may have a role 
in the tissue remodelling associated with lung function abnormality in determining 
progi ession of disease.
There may be several reasons why the antibody response did not completely subside 
especially in subject 1 and 25. These subjects may well still be exposed to pigeons while 
socialising with other fanciers and they would certainly have had some avian exposure 
while attending the pigeon marking sessions. There may also be other additional 
exposure to avian exposure from bird feathers in duvets, pillows and soft furnishings. 
Antigenic dusts have also been measured within the home of fanciers and can persists for 
up to 18 months in the home environment after removal of pigeons and this may explain 
the slow resolution of IgG avian antibody response or clinical improvement (126)
This population studied showed that the prevalence of probable PFL in that community 
was around 25% and sub-clinical inflammatory changes are common among the pigeon 
fanciers and this may be predictive of disease progression
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CHAPTER 3
TREND OF IMMUNE 
SENSITISATION AMONG PIGEON
FANCIERS
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1. SUMMARY
There are 80,000 registered pigeon fanciers in the UK. Many of them have been involved 
in this hobby for a long time. The Blackpool Pigeon Show is an annual event where 
pigeon fanciers from all over the country gather to participate in this event. The British 
Pigeon Fanciers Medical Research Team have been part of this annual event where 
fanciers are able to seek advice and have their blood tested for evidence of sensitisation 
towards avian antigen. This study looked at the trend of sensitisation among the pigeon 
fanciers attending the Blackpool Show over a 13 year period.
There was an increase in the number of fanciers volunteering to provide blood samples 
over that period and a total of 4045 blood samples were collected. In 1991 the majority of 
fanciers had no evidence of sensitisation and less than 30% had moderate or high levels 
of sensitisation. This is in contrast to 2003 where over 70% had moderate or high levels 
of sensitisation. Therefore there seems to be a change where the majority of pigeon 
fanciers now show a positive antibody response towards avian antigen. This response 
coiTclates with the symptoms experienced with their pigeons where the strongest 
responses are the most symptomatic. The majority of fanciers perform some form of self 
regulatory measures to reduce avian antigen exposure and are able to continue with their 
hobby despite evidence of sensitisation. When the data from Blackpool were compared 
to different centres and populations, the level of sensitisation among the fanciers seems to 
be similar.
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2. Introduction
No studies have been performed to look at the changes in the trend of immune 
sensitisation among pigeon fanciers over a period of time. It has been known for a long 
time among pigeon fanciers about the intolerance of their birds that was different from 
orthinosis (127,128). This intolerance has been described in 1897 among the gaveurs de 
pigeons who force fed thousands of pigeons for market in Paris. They described the 
typical pattern of pigeon fanciers lung (129). However, Reed and colleagues described 
the first clinical report describing alveolitis caused by avian exposure in 1965 (130). By 
the 1980’s there were still many fanciers doubting the existence of PFL and potential 
damage to their health as they contribute their symptoms to being part and parcel of their 
hobby mainly because they are afraid to be told to give up their pigeons. The British 
Pigeon Fanciers Medical Research Team has been instrumental in educating pigeon 
fanciers of the existence of the disease and potential detrimental to their health if 
symptoms are ignored. With the development of facemasks many fanciers are able to 
reduce their exposure to avian antigen and experience less symptoms whilst continuing 
with their hobby.
Apart from providing education. The British Pigeon Fanciers Medical Research Team 
also has been offering fanciers a chance to check their antibody levels to avian antigen. In 
this study we reviewed the trend of IgG antibody response among pigeon fanciers from 
the data collected from pigeon fanciers attending various pigeon shows and samples sent 
by their GP were reviewed. The Blackpool Pigeon Show is the biggest pigeon show in 
the UK and most of the data were derived fr om Blackpool. This data were compared with 
the data from Birmingham and Newcastle in 2000. Data from samples received fi'om GPs 
were also reviewed.
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3. Methods
Fanciers attending pigeon shows were invited to voluntarily fill a self-completed 
questionnaire (Appendix A) and provided a 5ml blood sample.
Over 4045 samples from Blackpool Pigeon Show in January each year were collected 
from 1991-2003 (Figure 4). The samples from Blackpool in 2000 were compared with 
samples collected in Newcastle and Birmingham in 1999 and the samples received from 
GPs. From this data the trend of immune sensitisation and symptoms over this period 
were analysed.
4. Results
The number of volunteer pigeon fanciers involved increased over the 13-year period. 
There was a significant increase in pigeon fanciers with high levels of sensitisation over 
the 13-year period (Figure 5). In 1991, 48% have little or no evidence of avian 
sensitisation and only 28% have moderate or high levels. In contrast 73% of fanciers 
have moderate or high sensitisation and only 20% have little or no response in 2003 
(Figure 6).
In a cross section review (n=612) of three different areas and population interestingly the 
level of sensitisation among pigeon fanciers is similar (Figure 7). When compared to the 
samples received from GPs all over the country from their patients attending the clinics 
the degree of immune response seems similar (Figure 8).
There was an overlap of IgG antibody responses between symptomatic and asymptomatic 
fanciers. However, the higher IgG responses, the more likelihood of fanciers 
experiencing symptoms and the strongest response occurs in the most symptomatic 
individuals. When the IgG responses were correlated with the symptoms complained by 
fanciers, a pattern of symptoms recognition emerges as in table 16.
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Figure 5. Trend of immune sensitisation between 1991-2003
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Antibody level (ue/mil Degree of sensitisation SvmDtoms reported
0-5 Not significant None
6-20 Mild Usually none recognised
21-50 Moderate Intermittent
Above 50 High Most aware of symptoms
Above 100 Very High Almost always present
Table 16. Significance of IgG antibody levels and correlation with symptoms
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5. Discussion
PFL often goes unrecognised and frequently misdiagnosed as a chest infection, airway 
disease or idiopathic lung disease as the mode of presentation can be similar to these 
diseases. The majority of fanciers are concerned with their health and are aware of the 
association of exposure to their birds and possible symptoms that may develop.
The increase in the numbers of volunteers involved over the 13-year period reflects the 
increase awareness in the disease and their efforts to monitor their antibody response 
when they perfoim self-regulatory measures to control avian antigen exposure as they 
were infoimed of their antibody results and appropriate medical advice were also given 
with the results. There seems to be an increase in the trend of immune sensitisation 
among pigeon fanciers over the 13-year period. On average 10-15% of fanciers attending 
each year had already had their IgG levels checked in the past. Whether this reflects a 
true increase in avian sensitisation in this community or an increase in awareness of the 
disease and their efforts to monitor their antibody response with measures taken to reduce 
antigen exposure requires further research. The similar antibody response obtained from 
3 different areas and populations (Blackpool, Newcastle and Birmingham) and with the 
congruous results fi*om patients attending their GP may well suggest the prevalence of 
sensitisation among the pigeon fancier community.
This study has demonstiated that the majority of active pigeon fanciers do produce an 
antibody response. Symptomatic fanciers also tend to produce the strongest response. The 
vast majority of fanciers would experience the acute non progressive disease and 
continue with their hobby with some adjustment to reduce antigen exposure. Fanciers 
with acute progressive disease would have little choice but to give up their hobby because 
of the severity of symptoms. Those with little noticeable symptoms despite an antibody 
response are at risk developing insidious form of the disease and should be regarded as 
having sub clinical disease and should be encouraged to take steps to reduce antigen 
exposure. Further prospective studies measuring longitudinal antibody measurement may 
answer the question of whether these fanciers are at risk of developing clinical disease.
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CHAPTER 4
FACTORS AFFECTING ANTIBODY
RESPONSE
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1. SUMMARY
The majority of pigeon fanciers exposed to avian antigens demonstrate antibody and 
lymphocyte response. Fanciers that produce the strongest response tend to develop 
clinical symptoms requiring some adjustment to their daily activities with their pigeons. 
However not all fanciers develop clinical symptoms despite evidence of sensitisation. 
Therefore antibody and lymphocytes seems necessary but not sufficient to cause clinical 
disease. Other factors are likely to be involved in the development of disease. Various 
constitutional and environmental factors have been identified that may influence the 
outcome of an individual of developing disease or not (Table 7).
Specific IgG antibody to avian antigen is an important component in the diagnosis of 
PFL. It is a good marker for monitoring avian exposure and proves recent exposure to 
avian antigen. In this study various constitutional and enviromnental factors are measured 
against the immunological response in pigeon fanciers measured by avian IgG antibody. 
Smoking is one of the strongest factors that suppress the antibody response although it 
appears to be reversible. The ability to mount an antibody response increases with age but 
is not influenced by the amount of avian exposure measured by number of birds kept, 
years of involvement in the hobby and the amount of hours spent in the loft in a week. 
This suggests that other factors are more important than the amount of antigen exposure 
itself in determining the outcome of the immunological response.
The incidence of PFL also increases with a higher antibody response and the number of 
pulmonary and systemic symptoms experienced by the fanciers correlates with the 
production of antibody. However there was no relationship established between IgG 
antibody and lung function in the fanciers studied.
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2. Serum IgG antibody response to avian antigen
Pepys et al (1961) first described the association between antibody and extrinsic allergic 
alveolitis in a farmer with précipitants of an extract of thermophilic actinomycetes gi'own 
from mouldy hay. Reed at al (130) described the significance of semm précipitants 
against pigeon serum and the association of pigeon exposure and interstitial lung disease. 
IgG remains the predominant antibody produced although IgM and IgA classes are also 
produced in pigeon fanciers with or without evidence of symptoms of PFL. These 
antibodies can also be detected in bronchoalveolar lavage, sputum and saliva in 
individuals keeping pigeons (131)
Serum precipitating antibody was considered a valuable diagnostic index for 
hypersensitivity pneumonitis (HP) in a recent review of the diagnostic criteria for HP. 
The diagnostic significance of these précipitants has been questioned in the past as a high 
incidence of semm antibody has been reported in asymptomatic individuals exposed to 
the relevant antigen (132-136). Due to its simplicity, the identification of precipitating 
antibodies by countercurrent immunoelectrophoresis remains the most widely used 
technique to aid the diagnosis of HP. However this technique provides no quantitative 
information on antibody concentrations or immunoglobulin classes and lacks analytical 
sensitivity. Cases of undiagnosed HP have been reported attributed to wrong choice of 
antigens, underconcentrated sera or improper quality control (137), as there are no 
standard procedures for this assay. In one study it showed that false negative are common 
where 30-40% of patients with proven farmers lung disease had no detectable précipitants 
to commonly tested antigen including Saccharopolyspora rectivirgula, Aspergillus 
species and Thermoactinomyces vulgaris (138).
It has been recommended recently that the assessment of interstitial lung disease should 
include testing for antibody against antigen associated with HP and these serological tests 
should be quantitative to improve national quality control. (135). Accordingly, 
enzymeimmunoassays methods that are more sensitive, reliable and quantitative are 
replacing the precipitant technique (134). Studies have confirmed by using this
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quantitative method there is a difference in the mean IgG antibody levels between 
fanciers with PFL and asymptomatic fanciers (139-140). However there is still an overlap 
of values where some asymptomatic fanciers have elevated IgG levels and a small 
number of fanciers showing undetectable antibody levels despite describing classical 
symptoms of PFL.
Using this sensitive method, in this section the levels of IgG antibody levels against 
pigeon gamma globulin are measured in a large population of pigeon fanciers. This is to 
assess the humoral response to avian antigens and the influence of a variety of other 
factors in affecting this response.
Factors measured against antibodv response in pigeon fanciers
1. Smoking
2. Age
3. Avian exposure -number of birds, hours spent with bird, years of exposure.
The association of antibodv with symptoms and disease
1. Profile of antibody levels
2. Incidence of PFL and association with antibody response
3. Antibody response and lung function
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3. Factors measured against antibodv response in pigeon fanciers
i) Cigarette smoking
There is a diverse clinical and immunological response among pigeon fanciers exposed 
to avian antigens associated with PFL. Only a proportion of these pigeon fanciers develop 
the disease and some continue to remain seronegative for antibody production.
There is a reduced prevalence of PFL and other HP among cigarette smokers. Smoking 
appears to impair the humoral immune responses as smokers produce lower 
concentration of serum and BAL fluid IgG to avian antigens compared to non-smokers.
In the survey of 413 pigeon fanciers there were 91 smokers, 210 non-smokers and 113 ex 
smokers. Table 17 shows the distribution of IgG antibody level against avian antigens 
and the % of antibody positive subjects for each of the group. The mean antibody level in 
the smoking group is 32.4 (3-57) ug/ml and is significantly lower compared to non 
smoking group titre of 54.8 (33-75) ug/ml. The mean antibody level for ex smoker was 
54.1 (29-75) ug/ml suggesting that this antibody response is restored in subjects who 
stopped smoking and this immune impairment due to smoking is reversible. There were 
also more antibody positive individuals in the non-smokers and ex smokers.
ii) Age
The ability to produce a serum antibody response to avian antigens as a function of age 
was investigated among the 413 subjects. The mean age was 53.8 years and ranged 
between 15 and 83 years old. Figure 9 showed the age of the population appeared to be 
normally distributed. The antibody levels among the each age group are shown in table 
18 and figurelO. As expected, the number of years involved in the hobby increased with 
age. There is a significant correlation between age and IgG response (Figure 11,1-0.115, 
p=0.019).
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Smokers Non smokers Ex smokers
Number of fanciers 91 (22%) 210(51%) 113 (27%)
Antibody positive 64 (70%) 192 (91%) 101 (89%)
Antibody level (ug/ml) 32.4 54.8 54.1
Tablel7. Number of antibody positive and mean IgG antibody response in the 
smoking, non smoking and ex smokers group
No of fanciers
<20 21-30 31-40 41-50 51-60 61-70 71-83
Age
Figure 9. The number of fanciers within each age group
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Number of Number of years
Age range fanciers IgG (ug/ml) involved
<20 2 1 8
21-30 11 26.8 12
31-40 40 45.3 17
41-50 105 48.7 22
51-60 126 51.5 30
61-70 106 53.6 39
71-83 23 47.6 43
Table 18. Distribution of fanciers according to age and IgG antibody results
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Figure 10. The increase in IgG antibody responses with increasing age group
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Figure 11. Significant correlation between age and IgG antibody response to avian 
antigen
Total of Mean lgG(ug/ml) for Mean IgG (ug/ml) for
of birds Non smokers Smokers fanciers all fanciers non smokers
25 13 3 16 56.7 62.3
50 24 77 101 51.8 57.5
75 18 68 86 47.4 51.2
100 31 101 132 46.5 52.7
125 3 8 11 58.8 59.2
150 2 18 20 47.2 50.7
175 3 18 21 72.3 77.1
200 2 8 10 51.1 54
Table 19. The IgG antibody results of 397 fanciers including non smokers according to 
the number of birds kept
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It seems that with increasing age and avian exposure, the ability to mount an antibody 
response increases. However this high level of IgG antibody may not necessarily translate 
into clinical symptoms allowing these individuals to continue with their hobby. This 
picture is distorted by the fact that individuals with severe symptoms or those with acute 
progressive disease will stop avian exposure completely.
iii) Avian exposure
The antibody response to avian antigen is likely to be influenced by the extent of 
exposure to these relevant antigens. Fink and colleagues (141) proposed an exposure 
index to include the length of time spent with birds and the number of birds. They 
suggested that there was a higher incidence of précipitants in the individuals with a 
greater exposure index. This relationship is reviewed in this section. The IgG antibody 
levels are measured against several measurable avian antigen exposures including 
number of birds, length of exposure in one week and number of years involved with the 
birds in 397 pigeon fanciers.
a) Number of birds kept
Increments of 25 birds were taken as a reasonable scale of the numbers of birds kept in 
the lofts. The average number of birds kept was 85. Table 19 shows the mean IgG results 
according to the number of birds kept. There was no correlation between the number of 
birds kept and IgG responses (r=0.25, p=0.55) even after smoking habit was taken into 
account (r=0.15, p=0.72). Overall the non-smoking group had a higher antibody 
response.
b) Years of avian exposure
The number of years of avian exposure is related to the age of fanciers and apart ft om 
the youngest age group the number of birds kept was almost similar (Table 20). There 
was no significant difference in mean IgG antibody levels between the study groups and 
no significant correlation between the number of years involved and IgG responses 
(Table 21, i -  0.047, p= 0.347).
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Number of Years Number o1
fanciers Age range involved birds
2 <20 8.5 40
11 21-30 11.8 82
40 31-40 16.9 84.6
105 41-50 21.8 87.7
126 51-60 29.6 88.7
106 61-70 39 85.3
23 71-83 43.2 90.3
Table 20. Number of years involved with pigeon fancying and number of birds kept 
according to age gr oup
Years of 
involvement IgG (ug/ml)
<10 46.6
10 51
20 47.8
30 53.4
40 52.8
50 49.2
60 51.6
Table 21. IgG antibody response according to the number of years involved in keeping 
birds
Weekly hours contact Number of fanciers IgG (ug/ml)
0-10 126 50.3
20 141 51.2
30 68 48.6
40 27 49.4
>40 15 47.5
Table 22. IgG response according to the number of hours in a week spent in the lofts
68
Therefore the increasing number of years with avian antigen exposure does not seem to 
influence IgG antibody production.
c) Weeklv hours of avian antigen contact 
The average weekly hours contact with pigeons was 18.4 hours for 377 fanciers 
surveyed. Table 22 shows the average IgG antibody level for each group divided by the 
number of hours spent with their pigeons in a week. There was no significant correlation 
between the number of weekly hours spent with their pigeons and IgG antibody response 
(r--0.02, p=0.69). It would seem that increasing weekly avian contact, like the other 
measures of increasing avian exposure, does not influence the amount of IgG antibody 
production. However it is important to emphasis that most fanciers are aware of their 
symptoms and may self regulate their antigen exposure by reducing their exposure time 
as a compromise between their symptoms and hobby.
4, The association of serum IgG with diseases
i) Profile of antibodv levels
The serum IgG antibody to avian antigen of 424 fanciers were measured and divided into 
levels of immune sensitisation as in figure 12. The mean IgG level was 49.2 ug/ml for the 
whole group and the highest level was 121ug/ml. 86 (20%) of the fanciers had little or no 
evidence of sensitisation. 236 (55%) had IgG levels above 50ug/ml.
ii) Incidence of PFL and association with antibodv response
In this section, the number of respiratory and systemic symptoms experienced (Table 23) 
and IgG antibody levels are reviewed in 422 pigeon fanciers. Fanciers describing at least 
one systemic and one respiratory symptom related to contact with their pigeon occurring 
on a regular basis are considered to have probable PFL. 158 fanciers (37%) were 
considered to have probable PFL having fulfilled the criteria above. The incidence of 
disease was increased from 28% to 42% in fanciers with IgG antibody level above 
30ug/ml.
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Figure 12. Distribution of fanciers according to IgG responses
Pulmonary symntoms Systemic symntoms
Dyspnoea Shivery
Upper respiratory tract symptoms Fever
Chest tightness Sweating
Wheezing Tiredness
Dry cough Aching muscles
Flu like symptoms
Table 23. Pulmonary and systemic symptoms complained by pigeon fanciers
Number of fanciers (%) IgG levels (ug/ml) No of average symptoms
66(15.6) 0-5 2
44(10.4) 6-20 2.8
81(19.2) 21-50 2.6
138(32.8) 50-75 3
76(18) 75-100 3.8
16(3) >100 3.4
Table 24. The average number of symptoms complained in each IgG antibody increment
group
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Of the 422 fanciers studied, 88 fanciers denied having any symptoms whatsoever 
although their average IgG antibody level in this asymptomatic group was 40 ug/ml. The 
number of symptoms complained for each antibody increment groups are illustrated in 
table 24. Fanciers with increasing number of complaints had a higher average IgG 
antibody level as shown in figure 13 (1-O.I8, p=<0.05). This shows that fanciers with 
higher IgG antibody levels are likely to become more symptomatic with classical PFL 
features.
iii) IgG antibodv and lung function
64 pigeon fanciers attending a pigeon show conference were involved in this study. The 
aim of this study was to determine any relationship between antibody response and 
airflow limitation in pigeon fanciers. Fanciers filled in a self-completed questionnaire, 
gave 5ml of blood for IgG antibody measurement and performed a lung function test with 
a spirometry according to the ATS guidelines. The fanciers were divided into 3 gioups of 
symptomatic non smokers, asymptomatic non-smokers and asymptomatic smokers. The 
results are shown in table 25. There was no significant difference in lung function 
measured by spirometry in the 3 groups. There was a significant difference in IgG 
antibody response between smokers and non-smokers where smokers had a much lower 
level response compared to the two non-smoking groups. However the asymptomatic 
non-smokers have the highest average IgG levels. There was also no correlation between 
lung function and IgG response (FEVl r =-0.17 p=0.18, FEVl/FVC ratio r = -0.12 
p=0.16, FEF25.75 r = -0.154 p= 0.22).
Therefore IgG antibody levels seems to be an unreliable test as an indicator of possible 
airway limitation in pigeon fanciers but further long term studies are required to 
determine whether these individuals are more prone to develop airflow limitation in the 
future if they persistently remain antibody positive This study also showed that 
asymptomatic non-smokers do develop a significant humoral response and in this group 
the response is higher than the symptomatic group although in cigarette smokers the 
responses are suppressed.
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Figure 13. Number of symptoms experienced in relation to IgG antibody response
Symptomatic Asymptomatic Smokers
n 26 22 16
F VC (% meas) 102 (93-109) 107(100-116) 108(90-124)
FEV1 (% meas) 95 (87-108) 96 (86-105) 97 (82-108)
FEVl/FVC ratio 74.7 (69-84) 71.7 (66-78) 73.8 (70-79)
FEF 25-75 (% meas) 74.5 (48-100) 69.5 (52-95) 71.7 (50-80)
IgG (ug/ml) 49(18-83) 61.4 (32-86) 18(3-28)
Table 25. Spirometry and IgG antibody results in 64 volunteer pigeon fanciers in 3 
groups
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5. DISCUSSION
An important step in the production of antibodies is the antigen specific interaction 
between a T helper lymphocyte and a B lymphocyte, which leads to their mutual 
activation. The antibody response to antigens requires the relevant B cell recognising 
antigen with its surface Ig receptor and receiving certain activation signals from CD4+ T 
helper cells. T cell recognition of antigens bound to class IIMHC molecules on the B cell 
surface and co-stimulatoy signals lead to T cell activation and secretion of T helper 
lymphocytes. Genetic factors are likely to control the responsiveness to the antigen, the 
ability and extent of antibody production and the development of pneumonitis.
As mentioned in the introductory chapter other environmental and constitutional factors 
may affect the clinical outcome to individuals exposed to avian antigens. In this chapter 
we reviewed the effects of various parameters including smoking habit, age and avian 
exposure on the antibody response.
One of the strongest environmental factors affecting the antibody response is cigarette 
smoking. Pigeon fanciers who smoke have a lower IgG antibody response compared to 
non-smokers (142,143). Previous studies have also confirmed a lower incidence of 
farmers’ lung and in other causes of HP in non smokers (144-146). This suggests that 
smoking suppresses humoral response to antigens. The effects do not seem to be 
permanent as the antibody levels of ex smokers return to similar levels as non-smokers. 
In the past it was thought that smoking causes airway obstruction resulting in proximal 
deposition of inhaled antigen preventing access to the alveoli where the disease is most 
prominent (147). However the global influence of cigarette smoking on the immune 
system is still not fully understood. It has been shown that smoking increases the alveolar 
neutrophils and macrophages and changes their physical properties and this may suppress 
the lymphocyte ratio. Alveolar macrophages play an important role in the regulation and 
inflammatory responses. Alveolar macrophages also collaborate with lymphocytes in 
generating specific immune responses, including antigen presentation (148). In cigarette 
smokers, alveolar macrophages exhibit reduced responsiveness towards liposaccharide 
(EPS) due to inhibition of production of TNFa and IL-6 resulting in decrease resistance
73
against foreign invading pathogens. The production of other cytokines such as ÏL-1 and 
IL-8 has also been observed (149). Studies in patients with farmers lung have shown that 
smokers with farmers lung had more frequent illness, more likely to develop insidious 
than acute symptoms, have worse lung function and had poorer 10 year survival 
compared to non smokers with farmers lung (150). Although PFL appears to be more 
common in non smokers, the prognosis may be worse in smokers. Therefore smoking 
should be strongly discouraged among pigeon fanciers.
With increasing age there was a progressive tendency towards producing an antibody 
response. In contrast, previous studies showed that increasing age with more years of 
avian exposure had progressively lower mean antibody level. This was thought to be due 
to a desensitising mechanism, which has been shown in animal studies involving 
prolonged exposure to inhaled or intravenous antigens (151-154). This desensitisation is 
associated with gradual resolution of ganulamatous mononuclear cell infiltrates in the 
lung. Desensitised animals become refractory to the development of inflammatory 
responses for more than 2 months and following the refractory period an anemnestic 
response can be induced with repeated antigen challenge. Experimental studies have also 
shown that lipo-oxygenase inhibitors and suppressor factors produced from macrophages, 
NK cells and T cells can modulate and dampen the granulamatous inflammatory lesions 
in the lung after repeated antigen exposure (154-156).
However, these results from this study need to be interpreted with caution as 
symptomatic fanciers perform self regulatory measures which reduce the antigen 
exposure controlling their symptoms and fanciers with severe symptoms may need to 
stop exposure completely whilst asymptomatic seropositive fanciers carry on with their 
activities as usual.
This study looking at the role of antigen exposure towards mounting an antibody 
response showed no clear association. Fink et al (141) found that the presence and 
intensity of serum précipitants to avian antigens are related to exposure index rather than 
with symptoms in a survey of 200 pigeon fanciers where none described symptoms
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typical of PFL. In this study the antigen exposure measured by the number of birds kept, 
total weekly hours spent in pigeon lofts and years spent in the sport we did not find a 
correlation between antibody response and increasing antigen exposure. However the 
number of symptoms expressed by fanciers correlated with an increase in the antibody 
response and the incidence of PFL is highest in the most vigorous response. Therefore, in 
this group of fanciers it may be reasonable to conclude that additional constitutional and 
environmental factors are more important than the total antigen exposure itself, in 
determining the antibody response to these inhaled antigens. The level of IgG antibody is 
determined by the host immunological responses rather than the duration or intensity of 
antigen exposure.
In this study of a large population of pigeon fanciers the majority of fanciers had 
evidence of sensitisation (80%) when the IgG antibody was measured by the ELISA 
technique. This is in contrast with previous studies of HP where the reported incidence of 
precipitating antibody ranged from 11% to 60% (157,158).
Using this sensitive technique, this study of 412 pigeon fanciers showed a clear 
association between increase incidences of PFL with progressively higher IgG antibody 
levels. This IgG antibody response reflects exposure to antigen and the higher response 
reflects increasing symptoms. Therefore fanciers with high levels of IgG antibody even 
without any noticeable symptoms should be advised to take precautionary measures to 
reduce antigen exposure as they may progress to develop the clinical disease. There are 
fanciers who reported significant symptoms despite little or no evidence of sensitisation. 
Their symptoms may well be because of other diseases that had developed while being 
within the loft environment. There are many initant dusts that are inhaled within the loft 
and can cause symptoms similar to PFL, The dust in the pigeon lofts have been shown to 
contain various bacterial and fungal products such as bacterial lipopolysaccharide, fungal 
beta glucan (21), teichnoic acid and C substance like carbohydrate material (159). Other 
antigens such as pigeon feather mites can constitute up to 10% of the weight of the 
feather and storage dust mites and cause clinical symptoms of asthma or rhinitis (160- 
161). Human ornithosis following contact with pigeons may also occur. Chronic 
exposure of irritant dusts such as grain dust (162) can lead to the development of chronic
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bronchitis (9,10). The influence of these antigenic dusts and the additional descriptions of 
asthma and rhinitis can complicate matters in making a diagnosis. How important is the 
exposure to these airborne toxins or allergic substance is unknown and further air 
sampling studies along with serial measurements of immune response, lung function and 
clinical status will help in defining some of the clinical symptoms described.
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CHAPTER 5
ANTIGEN AND ENDOTOXIN 
INDUCED CYTOKINES IN PFL
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1. Summary
The immune-pathogenesis of pigeon fanciers lung (PFL) is uncertain but avian-antigen 
specific antibody and lymphocytes appear necessary but not sufficient for disease. 
Therefore, the involvement of pro-inflammatory and T cell regulatory cytokines were 
investigated as an additional component required for the expression of disease. Based on 
a structured questionnaire, 21 pigeon fanciers with classical symptoms of PFL and 27 
matched for age and avian exposure with no symptoms and 12 control subjects with no 
avian exposure were interviewed and blood samples were taken for measurement of IgG 
antibody and lymphocyte proliferative responses to avian antigen. The proinflammatory 
and regulatory cytokines stimulated with either antigen or bacterial endotoxin were also 
measured.
Subjects with classical symptoms of PFL had an increase in avian-antigen specific serum 
IgG antibody and blood lymphoeyte proliferative responses. There was no significant 
difference in the constitutive or endotoxin-inducible level of acute-phase pro- 
inflammatory cytokines between the study gioups. The symptomatic pigeon fanciers had 
a dose-dependent increase in antigen-induced TNFa, IL-ip, IL-6, IL-8 and IL-18 and the 
antigen-induced cytokine levels con'elated with the avian-antigen specific serum antibody 
level.
The production of pro-inflammatory and immuno-regulatory cytokines in response to 
endotoxin was noimal. However there was a dose-dependent antigen-specific production 
of these cytokines that was significantly associated with susceptibility to disease. The 
levels of these cytokines correlated with the avian antibody titres. This suggests that the 
cytokine production mediated by immune complexes was quantitatively and qualitatively 
different from the cytokine profile produced by endotoxin and may predispose to disease.
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2. Introduction
The acute symptoms of PFL include shortness of breath, cough, fever and myalgia 
suggests both local pulmonary and systemic acute phase reaction. The majority of 
fanciers do produce an antibody response to avian antigens but many remain without 
symptoms. The immune-pathogenesis is still um'esolved but avian-antigen specific 
antibody and lymphocytes appears necessary but not sufficient for disease.
Cytokines are signal molecules controlling the state of activation of all local 
immuno competent cells, in both hypersensitivity reactions and allergic responses taking 
place in the lung. There is evidence supporting the paradigm that a complex network of 
cytokines governs the initiation, maintenance and resolution of an immune response 
(164-166). Therefore, the involvement of pro-inflammatory and T cell regulatory 
cytokines may be an additional component required for the expression of disease (167). A 
number of animal model studies have been performed looking at the role of cytokines in 
the production of granulamatous pulmonary infiltrates closely resembling human allergic 
alveolitis. A range of cytokines is produced and the pro inflammatory cytokine TNFa is 
perhaps the most important in the development of experimental granulomas. The 
distribution of these cytokines and the genetic polymorphism, which determines the 
ability to produce the amount of cytokines, may determine the onset of clinical 
expression and progression of the disease. TNFa, which has been shown to be an 
important mediator in HP (168-172) in both human and animal studies is mainly 
produced by alveolar macrophages, plays a critical role in lung injury including the 
regulation of fibroblast growth via induction of IL-6, release of other lymphokines 
including IL-1 and IL-6 and increases prostaglandin production (173-175). Antisera 
against recombinant TNFa have been shown to reduce pulmonary gianuloma response 
(18). Pro inflammatory cytokines such as TNFa , IL-lp, IL-8 and IL-6 may be 
responsible for the acute phase reaction in PFL causing fever and leucocytosis. Alveolar 
macrophages also produce T cell regulatory cytokines IL-12, IL-15 and IL-18, which can 
polarise lymphocytes primarily towards a Th-l-type response (176). In this study we 
reviewed the role of these pro inflammatory and regulatory cytokines (Tables 26 and 27) 
in a group of pigeon fanciers.
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TNFa - actively produced by lung macrophages. Plays a critical role in lung injury and 
regulation of fibroblast growth via induction of IL-6. Essential for cell recruitment at sites 
of inflammation and acts as an early response cytokine in the promotion of a cytokine 
cascade (164). Releases other lymphokines (IL-l,GM-CSF,IL-6) and increases 
prostaglandin production. Chronic overexpression of TNFa and IFNy and the 
dysregulation of TNF-R(receptor)/TNF-L(ligand) causes persistence and progression of 
inflammatory pulmonary disease and can lead to chionic recruitment of inflammatoiy 
cells, which once in tissues, assemble gianulomatous structures.
IL -1 -  Produced in response to inflammatory stimuli. Provides accessory growth factor 
activity for inflammatory lung T cells (165). Stimulates T helper cells, which are induced 
to secrete IL-2 and to express IL-2 receptors. Regulates the development of alveolitis by 
promoting the adhesions of neutrophils, monocytes and T cells by enhancing the 
expression of adhesion molecules such as ICAM-1/CD54 and ELAM/CD62E. Promotes 
fibroblast proliferation and collagen production and is involved in the development of 
lung fibrosis.
IL -6- A variety of chronic pulmonary inflammatory diseases including sarcoidosis, 
tuberculosis and interstitial lung disease associated with autoimmune lung disorders are 
thought to involve dysregulation of IL-6 production. IL-6 influences antigen specific 
immune responses, potentiates inflammatory reactions and is also involved in controlling 
fibroblast proliferation.
IL -8  -  Stimulates the accumulation of neutrophils, activated CDS and monocytes in 
hypersensitivity pneumonitis
Table 26. Proinflammatory cytokines
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IL -12  -  Involved in Thl immune responses and stimulates activated T lung cells and NK 
cells. Induces ThO versus Thl shift and in synergy with IL-15 favours the contact 
between activated T cells and antigen presenting cells. Acts by interacting with specific 
receptors (IL-12RP) expressed by lymphocytes during most Thl driven diffuse lung 
disease.
IL -15 -  Involved in the development of T cell alveolitis by supporting the growth and 
chemotaxis of T cells. It also acts as a co stimulatory factor for production of other 
cytokines and chemokines (CXCL8/IL-18,GM-CSF,IFNy and TNFa).
IL -18 -  Previously known as IFN-y-inducing factor and is almost similar in its activity to 
IL-1. Simulates IFNy production and causes inflammation by inducing the synthesis of 
pro inflammatory cytokines TNFa, IL-6, IL-8 and IL-lp. The regulatory cytokines IL-18, 
IL-12 and IL-15 act on Thl cells synergistically to induce IFNy towards a Thl response 
while inhibiting the production of IL-10.
Table 27. Regulatory cytokines
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3. Aims of study
The aim of this study was to investigate whether pigeon breeders with symptoms typical 
of PFL displayed disproportionate amounts of monocyte-derived pro-inflammatory and T 
cell regulatory cytokines when stimulated non-specifically with bacterial endotoxin or 
specifically with avian antigen in vitro.
4. Subjects and Methods
60 non-smoking pigeon fanciers attending a National Convention of Pigeon Fanciers 
volunteered for assessment. The volunteers filled in a self completed questionnaire 
(Appendix A), performed a spirometry test based on the ATS guidelines on performing 
spirometry (120) and provided a blood sample (5ml).
Subjects were considered symptomatic if they have at least one classical respiratoiy and 
one classical systemic symptom related to contact with their pigeons on a regular basis. 
Based on the self completed questionnaire (Appendix A), 21 described classical 
symptoms of PFL and 27 matched for age and avian exposure had no symptoms. Blood 
samples were taken along with 12 control subjects with no avian exposure.
Serum IgG antibody against avian antigen was quantified by enzyme linked 
immunoassay ELISA (Appendix B). Lymphocyte proliferative responses to avian antigen 
were quantified by tritiated thymidine incorporation in 7 day whole blood assay. 
Supernatant fiom cultures unstimulated or stimulated with either antigen or endotoxin 
were harvested after 2 days and cytokine levels were measured by commercial EIA. 
Statistical analysis was done using Minitab software using paired T test and Pearson 
correlation coeficient
5. Results
There were no significant differences in the demographics (age) nor the indices of avian 
exposure between the study gi oups of pigeon fanciers with and without a history of
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symptoms in keeping with PFL. The measures of pulmonary function were lower in those 
with symptoms suggestive of PFL (Table 28).
Comparison between the study groups of pigeon fanciers with and without a history of 
symptoms in keeping with PFL demonstrated a more abundant avian-antigen specific 
serum IgG antibody and blood lymphocyte proliferative responses among those with 
disease (Table 29).
There was no significant difference in the constitutive or endotoxin inducible level of 
acute-phase pro-inflammatory cytokines between the study gioups. The symptomatic 
pigeon fanciers had a dose-dependent increase in antigen-induced TNFa, IL-ip, IL-6 and 
IL-8. The endotoxin-induced levels of TNFa and IL-ip gi eatly exceeded the antigen- 
induced levels but in the case of IL-6 and IL-8 the antigen-induced cytokine levels were 
equivalent to or greater than the endotoxin-induced levels (Table 30).
The avian-antigen specific serum antibody level correlated with the antigen-induced 
TNFa level (r=0.36, p<0.05), the IL-lp level (r=0.45, p<0.01), the IL-6 level (r=0.6, 
p<0.001) and the IL-8 level (r=0.41, p<0.01).
There was no significant difference in the constitutive, endotoxin- and antigen-inducible 
level of monocyte-derived T cell regulatory cytokines IL-12 and IL-15 between the study 
groups (Table 31). The symptomatic pigeon fanciers had a dose-dependent increase in 
antigen-induced IL-18. The endotoxin-induced levels of IL-12 greatly exceeded the 
antigen-induced levels but in the case of IL-18 the antigen-induced cytokine levels 
approximated the endotoxin-induced levels.
The antigen-induced IL-18 level correlated with the avian-antigen specific serum 
antibody level. (i-0.46, p<0.01).
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Asymptomatic
n=27
Symptomatic
11=21
Age 53 (43-61) 47 (41-60)
Avian exposure
Years 20 (19-39) 20(10-37)
Hours / week 16 (7-25) 14 (7-20)
No of birds 47 (40-65) 60 (50-80)
Pulmonary function
FVC % 98 (79-114) 90 (77-101)
FEVl % 94 (78-104) 81 (64-99)
PEF % 110(93-121) 99 (73-112)
FEF 25-75 % 72 (50-92) 65 (33-101)
Table 28. The demographics, indices of avian exposure and measures of pulmonary 
function (median and i-q range) among pigeon fanciers with and without 
a history of symptoms in keeping with PFL
Asymptomatic Symptomatic p value
____________________ n-27_________________n=21_________________
Immunology
IgG antibody 44(9-59) 59(41-83) 0.03
CMIcpm 109(89-165) 159 (109-245) <0.05
Table 29. The avian-antigen specific serum IgG antibody (ug/ml) and lymphocyte 
proliferative responses (counts per minute) between the study groups of 
pigeon fanciers with and without a history of symptoms in keeping with PFL
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Controls
n=12
Asymptomatic
n=27
Symptomatic
11=21
TNFa
Constitutive 95 (34-108) 32 (16-58) 67 (48-112)
Endotoxin 1582 (864-2704) 2340(1000-3195) 2481 (1560-6556)
Antigen 5 ug 25 (13-101) 28 (7-63) 91 (32-161)
Antigen 50 ug 27 (12-86) 45 (16-402) 529 (77-1481)
IL-ip
Constitutive 9(5-23) 8(4-15) 14 (6-42)
Endotoxin 1184 (848-1697) 1123 (802-1432) 1219 (767-2342)
Antigen 5 ug 4 (0-22) 5 (0-60) 73 (11-177)
Antigen 50 ug 0 (0-9) 53 (0-218) 190 (25-448)
IL-6
Constitutive 495 (304-1050) 370 (221-715) 675 (142-950)
Endotoxin 6979 (6598-7614) 6521 (5556-7046) 7137 (6140-8094)
Antigen 5 ug 252 (123-422) 608 (161-1940) 2840 (351-6825)
Antigen 50 ug 216(100-374) 2531 (205-5712) 5340 (279-9533)
IL-8
Constitutive 2.5(1.1-5.2) 2.2 (0.8-4.5) 3.6(1.0-14.4)
Endotoxin 22.3 (19.9-23.7) 23.4 (20.2-26.0) 24.2 (19.5-28.2)
Antigen 5 ug 0.9 (0.3-3.2) 6.0 (1.5-23.8) 64.9 (8.5-210)
Antigen 50 ug 1.2 (0.4-106) 32.6 (6.6-48.8) 38.4 (5.1-186)
Table 30. The endotoxin and avian-antigen inducible acute-phase pro-inflammatory 
cytokine levels (pg/ml) in monocyte culture from pigeon fanciers and eontrols.
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Controls
n=12
Asymptomatic
n=27
Symptomatic
n=21
IL-12
Constitutive 93 (66-149) 71 (42-134) 90 (51-164)
Endotoxin 5774 (4431-6784) 6701 (3528-8832) 5693 (3556-8082)
Antigen 5 ug 90 (54-133) 67 (49-146) 104 (67-163)
Antigen 50 ug 96 (63-140) 121 (72-222) 137 (78-154)
IL-15
Constitutive 0 (0-0) 0 (0-0) 0 (0-4.5)
Endotoxin 59 (0-148) 12 (0-60) 3 (0-82)
Antigen 5 ug 0 (0-33) 0 (0-8) 0 (0-8)
Antigen 50 ug 0 (0-36) 0 (0-24) 0(0-1)
IL-18
Constitutive 65 (52-97) 52 (32-113) 101 (44-254)
Endotoxin 535 (258-791) 479 (282-939) 692 (444-1147)
Antigen 5 ug 37 (12-70) 100 (62-136) 232 (133-394)
Antigen 50 ug 66 (0-120) 246 (123-579) 285 (44-742)
Table 31. The in vitro endotoxin and avian-antigen inducible monocyte-derived T 
cell regulatory cytokine levels (pg/ml) in pigeon fanciers and controls
86
6. Discussion
A more abundant avian-antigen specific seram IgG antibody and blood lymphocyte 
proliferative responses were obseiwed among subjects with classical symptoms of PFL. 
However there is a large overlap between symptomatic and asymptomatic subjects. Many 
subjects still produce a positive antibody and lymphocyte response for avian antigen 
despite lack of clinical expression of symptoms. Therefore antibody appears necessary 
but not sufficient to cause disease. Animal models despite its limitations have shown that 
immune complex mediated lung inflammation may be mediated by proinflammatory and 
regulatory cytokines (65,178-180). This study explored the involvement of these 
cytokines and its association with the disease.
There was no significant difference in the constitutive or endotoxin-inducible level of 
acute-phase pro-inflammatory cytokines between the study groups. The symptomatic 
pigeon fanciers had a dose-dependent increase in antigen-induced pro inflammatoiy and 
regulatory cytokines TNFa, IL-1J3, IL-6, IL-8 and IL-18. This study did not show an 
increase in IL-12 or IL-15 although previous studies have shown an increase of these 
cytokines in patients with hypersensitivity pneumonitis (181,182). The antigen-induced 
cytokine levels correlated with the avian-antigen specific serum antibody level TNFa, 
IL-lp, IL-6, IL-8 and IL-18. The production of pro-inflammatory and immuno-regulatory 
cytokines in response to endotoxin was similar between the study gioups. However there 
was a dose-dependent antigen-specific production of these cytokines, which was 
significantly associated with susceptibility to disease. The levels of these cytokines 
correlated with the avian antibody titres. This suggests that the cytokine production 
mediated by immune complexes was quantitatively and qualitatively different from the 
cytokine profile produced by endotoxin and may predispose to disease.
The early activation of alveolar macrophages by specific antigen/antibody complexes, 
with release of these proinflammatory cytokines sets the stage for the development of 
PFL. Activated T cells of the Th 1 phenotype produces IL-2 and interferon gamma, 
which can lead macrophages to transcribe and release higher amounts of IL-1 and TNFa.
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This process probably contributes to the influx of CD 8+ cells seen in the lungs of 
affected individuals. Other cytokines may play an inhibitory role in the formation of this 
inflammatory response. Administration of XL-10 appears to down regulate the Thl 
responses with reduce numbers of pro inflammatory cells and down regulation of MHO 
class 11, B7 costimulatory molecule and expression on accessory cells (183).
With recent advances in technology, various genetic polymorphisms for production of 
enzymes and cytokines have been identified. It may be possible that a combination of 
these genes confer increase or decrease susceptibility to developing a particular disease. 
Selman et al identified the association of certain polymorphism and the expression of 
disease. The group found patients with PFL had an increase of the fiequency of HLA- 
DRB1*1305, HLA-DRQB 1*0501 and TNF-2 (-308) promoter allele but a decrease of 
HLA-DQB 1*0402 allele (184). The amount of pro inflammatory and regulatory 
cytokines produced at each stage may determine the onset and progression of disease and 
this amount is deteiTnined by each individual’s constitutional factors such as genetic 
polymorphism and environmental factors such as cigarette smoking or intercurent 
infections which can have an immunomodulatory effect on lymphocyte function. 
However, our knowledge regarding the potential mechanisms whereby cytokines function 
in the various stages of immune responses are derived from in vitro studies that are often 
difficult to translate into in vivo inflammatory events. The wide range of cytokine and 
inflammatory response observed under different clinical situation further complicates 
this. There is obviously a complex process involving an initial immune response to the 
development of granulomas and fibrosis mediated by immune complexes, pro 
inflammatory and regulatory cytokines. This response is modulated by other inhibitory 
cytokines or suppressor factors produced by various cells, which will dampen the 
response. This area of research is very important to give us further insight in our 
understanding into the pathogenesis of hypersensitivity pneumonitis.
CHAPTER 6
FEVl AMONG PIGEON FANCIERS 
CORRELATES WITH CD8+ 
LYMPHOCYTE COUNT
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1. Summary
The respiratory symptoms of PFL include shortness of breath due to restriction of gas 
transfer suggesting predominantly alveoli involvement. However, the known association 
with bronchial hyper-reactivity and with chronic bronchitis suggests that large airways 
may also be involved. Studies have suggested that an imbalance between cytotoxic CD8+ 
lymphocytes and helper CD4+ lymphocytes may contribute to the abnormal 
inflammatory process in the airways of patients with airflow limitation. This study looked 
at the correlation between FEVl and peripheral blood CD8+ lymphocytes among pigeon 
fanciers. The IgG antibody response and lymphocyte proliferative responses towards 
avian antigen were also measured.
Pigeon fanciers with classical symptoms of PFL had an increase in IgG antibody and 
lymphocyte proliferate response to avian antigens and a higher CD8+ lymphocyte count 
compared to asymptomatic fanciers. The FEVl of fanciers with PFL correlated 
significantly with the blood CD8+ lymphocyte count (r = -0.5, p 0.002).
It has been demonstrated previously that FEVl decreases with increasing years of avian 
exposure. This index of large airway function appears to be associated with lymphocyte 
phenotype and function. These observations support the hypothesis that large aiiways are 
involved, perhaps sub-clinically, in the disease process of PFL and lymphocyte 
imbalances are important in the pathogenesis of PFL.
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2. Introduction
Although the classical pulmonary abnormalities involves mostly at the alveoli level, the 
presentation of PFL includes involvement of the upper aiiivays. Some fanciers may 
present with symptoms suggestive of chronic bronchitis as their only symptom (9,10), 
Responses to pigeon antigens in peripheral blood T cells obtained from patients with PFL 
have been described (185-191). Recently there has been interest in abnormalities of T 
lymphocytes subsets in peripheral blood and in BAL fluid in patients with COPD. 
Patients with COPD have been reported to have an increase in CD8+ T lymphocytes in 
the airways, which might suggest that these lymphocytes are involved in the pathogenesis 
of airflow limitation (122,192,193). It has also been shown that in histopathological 
specimens of patients with COPD there is an increase in T lymphocytes and smooth 
muscle mass in the peripheral ahways suggesting the presence of small airways 
remodelling in these patients (194).
3. Aims of study
This study was to investigate the association of FEVl and CD 8+ T lymphocyte 
peripheral blood count among pigeon fanciers.
4. Subjects and Methods
Similar patients were used from the above study of 21 pigeon fanciers with classical 
symptoms of PFL and 27 matched for age and avian exposure with no symptoms and 12 
control subjects with no avian exposure based on completing a questionnaire 
(Appendix A). Apart from IgG antibody and lymphocyte proliferative response measured 
in the above study, oral temperature and lymphocyte phenotype was counted by flow 
cytometry (BD Ltd).
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5. Results
The demographics, indices of avian exposure and measures of pulmonary function among 
pigeon fanciers according to their history of symptoms in keeping with PFL is as the 
above study where there were no significant differences in any of these measures 
between the groups of pigeon fanciers apart from the lower lung function in fanciers with 
symptoms suggestive of PFL (Table 28).
The pigeon fanciers with probable PFL had a higher oral temperature, and demonstrated a 
more abundant avian-antigen specific serum IgG antibody, lymphocyte proliferative 
response and a higher CD8 lymphocyte count (Table 32).
The CD8 lymphocyte count was significantly associated with the FEV1%. (Figure 14).
6. Discussion
The BAL fluid specimens in patients with PFL shows an increase in both CD4+ and 
CD8+ T cells but the lymphocytosis is mainly a predominance of CD8+ T cells (195) and 
characterised by Thl dominant profile. Animal models have also suggested that the 
disease is characterised by a Thl type response (85) and there was a predominance of 
interferon gamma producing T cells (196), which could be further stimulated by addition 
of recombinant IL-12 and the addition of IL-10 redueed the production of interferon 
gamma (197).
The CD8+, cytotoxic T-lymphocyte subset has also been implicated in the pathogenesis 
of airflow limitation in patients with COPD. Among pigeon fanciers with symptoms 
suggestive of PFL there was an increase in CD8+ cells, and we described an association 
between FEVi and CD8+ lymphocytes in peripheral blood among all the pigeon fanciers. 
This finding implies that T lymphocytes might play a role in the pathogenesis of airflow 
obstruction in PFL. This suggests that the cytokines from CD8+ cells, perhaps gamma 
interferon, may have a role in the tissue remodelling associated with lung function
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abnoiinality. Among the asymptomatic group there is still a significant immune response 
with increase in IgG and lymphocyte proliferative response. These changes including the 
rise in CD8+ count among asymptomatic subjects might be a sub-clinical marker for 
subsequent disease. Increases in T cell response in asymptomatic fanciers have been 
reported although some differences in the response have been noted (189). It has been 
reported of apparently antibody negative individual showing lymphocyte transfoimation 
in response to pigeon antigens (198). One study have shown that a range of antigens is 
able to stimulate T cell responses from both symptomatic and asymptomatic exposed 
fanciers and a 220kDa protein appeared to be immunodominant and preferentially 
induced responses in patients with PFL (199).
T cell lymphocytes are clearly vital in the pathological immune response in PFL. It may 
be the differences in the T cell responses of each individual fancier that will determine 
the pattern of eytokine production, which in turn will provide protection or stimulation 
for progression of the immune response and subsequent disease (166,200).
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Asymptomatic
n=27
Symptomatic
n=21
p value
IgG antibody 44 59 0.03
(9-59) (41-83)
CMI cpm 109 159 <0.05
(89-165) (109-245)
Temperature 36.2 36.6 0.007
(35.6-36.5) . (36.3-37.0)
CD8 (cells/cmm) 1232 1568 0.03
(913-1540) (1122-1992)
Table 32. The avian-antigen specific semm IgG antibody (ug/ml), lymphocyte
proliferative responses (counts per minute), oral temperature and CD8+ 
lymphocyte count between the study groups of pigeon fanciers with and 
without a history of symptoms in keeping with PFL.
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Figure 14. Association between CD8+ and FEVl %
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Animal tends to tolerate inlialed antigens and develop immunological tolerance but in 
humans these antigen induce a powerful immune response in the lung often with clinical 
symptoms and development of diseases such as asthma, occupational lung disease and 
HP. The natural history of Pigeon Fanciers Lung is still partially understood and requires 
further study. In PFL there is an exaggerated immune response against inhaled avian 
antigen. The level of this response measured by serum IgG antibody against avian antigen 
reflects the degiee of local inflammation in the lungs. The persistence of antigenic 
stimulation and ongoing chronic inflammatory response leads to the development of 
granuloma or the development towards fibrosis.
Although the majority of fanciers develop antibody response, only a small number 
progiess to develop established disease. The prognosis seems to be very good in patients 
with acute non progressive recurrent disease where some adjustment to reduce antigen 
exposure is sufficient to control their symptoms within a few weeks or months and they 
are able to continue with their involvement with their pigeons. However further long teiin 
studies are required to answer the question of whether fanciers with sub clinical disease 
progress to develop establish disease. In some fanciers symptoms are non specific until 
they present to medical staff with the established chronic form of the disease and the 
progression of disease may continue despite avoidance of antigen. There is evidence that 
the long-term prognosis of farmer’s lung is poor where some patients continue to 
progress despite avoidance of antigen exposure and there seems to be several predictors 
of long term decline these farmers (55). Weather these prognostic indicators are similar to 
PFL requires further investigation. Patients in the chronic stage tend to slowly progress 
with irreversible lung damage leading to respiratory failure, cor pulmonale and ultimately 
death.
The 5-year longitudinal study among a cohort of pigeon fanciers showed deterioration in 
lung function over that period. However these changes did not translate into clinical 
symptoms. This is complicated by the fact that the majority of fanciers who remain active 
have good lung function and perfbroi self regulatory measures when they develop
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symptoms. Fanciers with severe symptoms with progressive disease and poor lung 
function would not have any choice but to give up their hobby. This study did not 
demonstrate any relationship between IgG antibody response to avian antigen and FEVl. 
Therefore, the magnitude of antibody response does not predict airflow limitation in 
pigeon fanciers at least in the short temi. There had been studies showing that the severity 
of airflow limitation in patients with COPD is associated with airway inflammation and 
an increased proportion in B cells in the airway wall and reduced proportions of blood B 
cells suggesting a migration to the site of airway inflammation (201,202). There was a 
relationship between IgG antibody response to avian antigens and imbalance of T cell 
lymphocytes. The ratio of these CD4+ and CD8+ T cell lymphocytes coiTelated with lung 
function of these fanciers suggesting this imbalance of T lymphocytes may play a role in 
airway inflammation and obstmction. This study showed no significant changes in 
symptoms reported over the 5 year period suggesting a state of equilibrium has been 
reached between the host and external antigen despite continued exposure and persistent 
antibody production. However the concern remains that this persistent antibody response 
underlies continuing immune activation and the absent of clinical symptoms may mask 
the progression to the chronic insidious forni of the disease (203-205).
The trend of immune sensitisation over a 13-year period showed a shift in the level of 
sensitisation among pigeon fanciers in the United Kingdom. This survey also showed that 
the majority of active fanciers showed evidence of antibody response and the 
symptomatic fanciers had the highest response. There remains a large overlap of antibody 
levels between symptomatic and asymptomatic fanciers which strengthens the argument 
that antibody is necessary but not sufficient to cause the disease.
It has been shown that the quantitative antibody measurement by ELISA is an important 
step in making the diagnosis of PFL and is a useful tool in managing the disease. The 
presenee of IgG avian antibody implies exposure to antigen and serial measurements of 
antibody response with clinical history and radiological appearance would indicate how 
successful was the antigen avoidance measures that has taken place. The serum IgG 
antibody response to avian antigen in a population of pigeon fanciers has demonstrated a
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range of responsiveness. 20% of fanciers showed no evidence of sensitisation despite 
being exposed to similar amount of antigen. The reason for this unresponsiveness, 
whether immunological tolerance, desensitisation or underlying genetic predisposition is 
uncertain.
There are various constitutional and environmental factors that will influence the 
susceptibility of an individual to produce IgG antibody response and the development of 
PPL. In this study we examined several of these factors and their influence in producing 
an antibody response. Cigarette smokers produce lower concentrations of semm IgG 
antibody and show a reduced prevalence of antibody positive fanciers. The mechanism 
for this inhibition and the cell biology of this protective effect is not fully understood. 
Smoking generally suppresses the humoral response and disrupts the alveoli macrophages 
functioning. This effect is reversible since the antibody levels in ex smokers are similar to 
non smokers. Despite PPL being more common in non smokers, the prognosis may be 
worse in smokers as it has been suggested they may develop the insidious chronic form 
of the disease. A study by Yoshio et al in Japan showed that there was a high smoking 
rate in chronic HP cases (110,206,207). Since smoking has been shown to inhibit the 
production of antibodies, it appears to prevent fanciers from developing the acute onset 
type of the disease, which would have encouraged them to reduce antigen exposure. 
Therefore smoking should be strongly discouraged among pigeon fanciers (208).
In the large group of pigeon fanciers that was studied, with increasing age the ability to 
produce more antibodies also increases. These individuals are in the state of equilibrium 
where they are able to continue with their hobby with some alteration to their antigen 
exposure and are able to keep any symptoms under control. When the amount of antigen 
exposure was measured by number of birds kept, number of years involved and number 
of hours spent in pigeon loft in a week there was no correlation with the magnitude of 
IgG antibody response. This suggests in this group of population where they counter a 
higli intensity antigen exposure on an intennittent basis, other factors are more important 
in influeneing antibody production to avian antigen.
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The symptomatic fanciers tend to produce a higher antibody response and the higher the 
antibody response the more likely of developing the disease. Fanciers with IgG level of 
above 50ug/ml almost certainly suffer from symptoms and would have to perform some 
self regulation manoeuvre to control their symptoms. There are fanciers who reported 
significant symptoms despite little or no evidence of antibody response to avian antigen. 
This may be because of other airborne antigens such as endotoxins that are present in the 
loft environment, which may cause wheeze and cough after acute exposure and 
symptoms of chronie bronchitis after chronic exposure. Bacterial and fungal materials 
that are present in the loft can also cause symptoms that are similai- to PPL.
Another constitutional factor that may influence the susceptibility of developing the 
disease is the distribution of cytokines and the genetic polymorphism that controls the 
production that may determine the onset of symptoms and disease. This study looked at 
the involvement of pro-inflammatory and T cell regulatory cytokines as an additional 
component required for the expression of disease. Symptomatic fanciers produced 
significantly higher levels of proinflammatory cytokines TNFa, IL-ip, IL-6, IL-8 and 
regulatory cytokine IT-18. This suggests that cytokines may play an important role in the 
pathogenesis of PPL. The symptomatic fanciers showed a higher level of IgG antibody, 
lymphocyte proliferation count and oral temperature. However there was a large overlap 
in immune response between the asymptomatic and symptomatic gi'oup. Studies looking 
at the interaction between these pro inflammatory cytokines and inhibitory cytokines and 
their effect in the development of pulmonary inflammation and progression of disease 
may have important clinical and therapeutic consequences.
There was also a raised antibody response in the asymptomatic group suggesting 
underlying subclinieal inflammation with a raised lymphocyte proliferation count and 
CD8+ count which may be a marker for progression to disease. The CD8+ count was also 
correlated to the FEVl measured, which suggests cytokines from CD8+ lymphocytes 
perhaps gamma interferon or the imbalance of T lymphocytes itself may be involved in 
the development of airflow obstmction.
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Subclinieal disease is common among pigeon fanciers and the evidence suggests there is 
ongoing inflammation in the individual host with an increase in immune and 
inflammatory response in the lungs and also in peripheral blood. A raise in the antibody 
response to avian antigen in asymptomatic subjects are associated with an increase of 
CRP, gammaglobulins, positive rheumatoid factor, total IgG and KL-6 levels, which 
indicates local lung injury (209). Therefore antibody positive fanciers should be 
counselled by the healthcare professionals with care and sensitivity to take precaution to 
reduce antigen exposure. Symptomatic pigeon fanciers would only contemplate giving up 
their pigeons only as a last resort after all the other measures are tried and found to be 
ineffective.
The pathogenesis and the natural history of PPL are only partially understood and many 
of the details of the cellular processes that are involved in the pathogenesis are still 
obscure (210). Most of this information is acquired from animal models, study of 
bronchoalveolar lavage fluids and biopsy samples from patients. The understanding of 
this immunological mechanism will provide an insight of the pathogenesis of the disease, 
development and targets in treatment of other causes of HP and interstitial lung disease as 
the immunological process are similar.
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APPENDIX A
SELF COMPLETED QUESTIONNAIRE
This questionnaire was based on the MRC questionnaire for chronic bronchitis and was 
modified to include details of avian exposure, symptoms of Pigeon Fanciers Lung, 
general respiratory symptoms and the fanciers past medical history, occupational and 
smoking details
Antigen Exposure:
1. Do you keep pigeons?
2. How long have you kept pigeons?
3. How many pigeons do you generally keep?
4. Have you been in contact with other species of birds?
5. If yes what species?
6. During the season how many hours per week do you spent with your pigeons?
7. Do you wear a mask when with your pigeons?
8. If yes, does it help with your chest?
9. Have you been diagnosed as having Pigeon Lung?
10. If so, who is treating you?
Svmptom data:
Are you aware of any of the following symptoms when you are, or have been, with your 
pigeons? Some of this can occur 2-3 hours after you have been with your birds and after a 
show or a marking session. This may also oecur when you have been cleaning out, or 
after a prolonged time in contact with your pigeon.
11. Shortness of breath?
12. Sneezing, blocked or runny nose?
13. Itchy or running eyes?
14. Tightness in the chest?
15. Shivery/eold feelings?
16. F ever/temperature?
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17. Sweating?
18. Wheezing?
19. A dry cough?
20. Tiredness?
21. Aehing muscles?
22. Have you noticed “Flu Like” symptoms in the evening or at night whieh have 
gone away in the morning?
23. If you have suffered from any of the previous symptoms, are they worse;
At the weekend?
After a pigeon show?
After cleaning out?
24. Have you had any of the above symptoms over the last week?
Respiratorv data:
25. Do you have a eough most days of the year?
26. Do you bring up any spit or phlegm?
27. Do you ever get short of breath when walking with others of your own age?
28. Were you chesty as a child?
29. Have you ever suffered from
Asthma/Hay fever/Dermatitis
Heart trouble
Tuberculosis
Bronchitis
Asthma
Pneumonia
Other chest diseases
30. Have you ever been exposed to coal, silica, asbestos or hardwood dust?
31. Do you, or have you ever smoked?
128
32. If the answer is yes
No of cigarette/day 
No of years
33. If you used to, how many years ago did you stop?
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APPENDIX B
Enzyme linked immunoassay
Serum antibody activity against pigeon semm gamma-globulin [PGG] antigen (40% 
saturated ammonium sulphate fraction), which is distinct from antigens in dietary hens' 
eggs [16], was measured by indirect enzyme-immunoassay (EIA) and optimised along 
with test sample dilutions by checkerboard analysis. Briefly, the assay involved coating 
96“well polystyrene microtitre EIA plates (Dynatech Ltd, UK) with the antigen at 
lOmg/L in bicarbonate buffer (0.02M, pH 9.6), at lOOul/well overnight at 4°C. The plates 
were washed three times in detergent buffer (phosphate buffered saline, 0.02M, pH7.4, 
containing 0.05% Tween-20, PBS-T). Serum samples were diluted optimally at 1:200 
with PBS-T and incubated in duplicate on the same plates at lOOul/well for 1 hour at 
room temperature, after which the plates were washed as above. Bound antibody was 
quantified using alkaline phosphatase conjugated anti-human IgG at dilutions 
recommended by the manufacturers (The Binding Site UK Ltd). After washing as 
before, the plates were incubated with the colourless substrate p-nitrophenyl phosphate 
(Sigma UK Ltd) at 1 mg/ml in 10% diethanolamine, pH 10.5, which is converted by the 
phosphatase to a yellow product with an absorbance at 405nm. The color (optical 
density) was measured by spectrophotometer (Dynatech Ltd UK) developed after 
approximately 30 min; the timing was approximate; allowing a reasonable distribution of 
color. The E405iun was proportional to the antibody activity if all other reagents are in 
excess. The specificity of the assay was established by inhibiting the antibody activity 
with excess free antigen before assay. The assay was unaffected by high 
immunoglobulin levels because there was no specific activity demonstrable in myeloma
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sera. The IgG antibody activity could be quantified by interpolation, using an optical 
density standard cui-ve horn serial dilutions of a standard serum which had been titrated 
by quantitative precipitation [15]. There were no equivalent standards for the other 
serum antibody isotypes, nor for antibody activity against other avian antigens, therefore 
the optical density units were used as a relative measure for the antibody activity.
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